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Abstract
Ischemia is a condition of decreased tissue viability caused by a lack of perfusion
which prevents the delivery of oxygen and nutrients to biological tissue. Ischemia
plays a major role in many clinical disorders, yet there are limited means by which
tissue viability can be assessed. The long-term objective of this research is to de-
velop a non-invasive or non-contact instrument for quantifying human tissue ischemia.
Skeletal muscle ischemia is evaluated at this stage because skeletal muscle is easily
accessible, its ischemia represents a clinical problem, and it can endure short periods
of ischemia without suffering permanent injury. The ischemia monitor designed for
this study is based on impedance spectroscopy, the measurement of tissue impedance
at various frequencies. This study had three major goals.
The first goal was to improve upon the design of an existing ischemia monitor to
achieve optimal system performance in a clinical environment. Major considerations
included electrode sterility, instrument mobility, and electrosurgical unit interference.
The second goal was to collect both impedance and pH data from human subjects
undergoing tourniquet surgeries that induce skeletal muscle ischemia and result in
changes of the tissue’s pH and impedance. The average recorded pH during ischemia
was 0.0053 pH units/minute and the average change in R0 was -0.1481 Ω/minute.
The third goal was to establish a relationship between parameters of tissue imped-
ance and pH utilizing neural networks. This goal was accomplished in three stages.
First, the optimal neural network type for classifying impedance data and pH val-
ues was determined. Based on the results, the backpropagation neural network was
utilized for all subsequent work. The input parameters of the neural network were
optimized using previously collected data. The number of inputs to the previously
developed neural network were reduced by 35% (13/20) with a maximum of a 3%
reduction in neural network performance. Finally, the neural network was trained
and tested using human impedance and pH data. The network was able to correctly
estimate tissue pH values with an average error of 0.044 pH units.
As a result of this research the ischemia monitor was improved, a methodology
for the use of the instrument in the operating room was developed, and a preliminary
relationship between parameters of impedance spectra and pH was established. The
results of this research indicate the feasibility of the instrument to monitor both
pH and impedance in a clinical setting. It was demonstrated that impedance data
collected non-invasively could be used to estimate the pH and level of ischemia in
human skeletal muscle.
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Chapter 1
Problem Identification
Ischemia is a condition of decreased tissue viability caused by a lack of perfusion lim-
iting the delivery of oxygen and nutrients to the tissue. This causes both physiological
and biochemical changes in the tissue. Ischemia plays a major role in many clinical
disorders, yet there are limited means by which tissue viability can be accurately
assessed. Methods available for ischemia determination include pH measurements,
magnetic resonance imaging, laser Doppler, fluorescin staining, tissue temperature,
visual inspection and other techniques that will be discussed in Chapter 4. However,
none of these methods meet the criteria of an “ideal” ischemia monitor which would
be [1]:
Harmless to the patient Harmless to the tissue
Simple Portable
Stable Accurate and Reliable
Quantifiable Rapid response time
Universally applicable Inexpensive
Continuous mode capable Discrete mode capable
Devices that monitor ischemia and tissue viability would be valuable during sur-
gical procedures as well as for regular diagnostic purposes.
1.1 Medical Conditions
There are numerous cases both in surgical and non-surgical situations where skeletal
muscle ischemia may occur. Surgical situations in which skeletal muscle ischemia
may occur include “bloodless” hand surgeries, microvascular transplantation of free
flaps, and cardiac catheterization. Some non-surgical instances in which skeletal
muscle ischemia may occur include compartment syndrome and diabetic foot. In
many of these cases irreversible tissue damage may occur due to the lack of medical
instrumentation capable of early detection/monitoring of ischemia level.
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Bloodless Hand Surgery
The soft tissues of the hands and feet are extremely well perfused. Therefore, when
surgery is performed on either the hands or feet, it is advantageous to limit the blood
flow to the tissue during the operation so that “bloodless surgery” can be conducted.
During “bloodless” hand surgery, a tourniquet is applied to the upper arm to restrict
blood flow and provide a “bloodless” field for the surgical procedure. The application
of the tourniquet for short periods of time induces mild reversible ischemia, but if left
in place for too long, permanent tissue damage can result. Therefore, if the surgery
lasts longer than an hour and a half, the surgeon has to deflate the tourniquet and
reestablish blood flow to the limb. Then, after a period of approximately fifteen
minutes, the surgery can be resumed. Many studies have been conducted in order to
determine the appropriate length of time that the tourniquet can be left in place, but
no time limit has been universally accepted [2]. In order to prevent permanent tissue
damage and ensure appropriate use of the tourniquet while enabling the surgeon to
extend the duration of the procedure to the safe maximum, an instrument that could
quickly, conveniently, and continuously monitor ischemia throughout any procedure
in which a tourniquet was employed would be of great value.
Microvascular Transplantation of Free Flaps
In the microvascular transplantation of free flaps (removing tissue from one part of the
body to another for purposes of reconstruction [3]), a healthy tissue flap is removed
from its original site, and attached in the area of reconstruction. The arteries and
veins from the tissue flap are then connected to those in the area of reconstruction
to ensure proper blood supply to the tissue. There is, however, a chance that an
artery or a vein will become occluded and ischemia will ensue. Ischemia occurs in
approximately 5 to 15 percent of surgeries, causing failure of the transplant in the
majority of these cases. If ischemia is detected early, corrective measures can be taken
and an estimated 75% of these flaps can be saved [4], yet an inexpensive, reliable, and
effective ischemia monitoring device that could detect the early onset of ischemia in
these cases is not yet clinically available. Preliminary work described in Section 1.2
has produced excellent results but requires an indwelling invasive probe.
Cardiac Catheterization
Cardiac catheterization is a common procedure by which a catheter is inserted into
the femoral artery and then threaded through the aorta into the heart. The catheter,
however, can cause problems by obstructing or slowing down the blood flow to the leg
especially in a patient with a swollen or partially obstructed femoral artery [5]. The
obstruction of blood flow may induce ischemia in the leg and during long procedures
can lead to tissue degradation. Presently, due to the complexity of the operation
and dangers associated with cardiac catheterization, almost no attention is paid to
the condition of the leg, so problems due to ischemia in the leg frequently go unde-
tected. There is no ischemia detection/monitoring device which will detect the onset
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of ischemia in the leg during cardiac catheterization.
Compartment Syndrome
Compartment syndrome results from an increase in pressure within a confined space
that leads to micro-vascular compromise, ischemia, and ultimately cell death [6].
Compartment syndrome can occur wherever there is a compartment that restricts the
tissues ability to swell outward, resulting in increased pressure and reduced perfusion
within the compartment. Regions of the body susceptible to compartment syndrome
are: hand, forearm, upper arm, abdomen, buttock, and entire lower extremity [7].
If compartment syndrome remains untreated, it leads to tissue necrosis and may
necessitate amputation of the affected tissue. An ischemia monitoring device could
facilitate the early detection of compartment syndrome allowing measures to be taken
to correct the problem.
Diabetic Foot
Diabetic foot is a condition found in diabetics where decreased peripheral circulation
and nerve sensation leads to chronic foot ulceration and bacterial infection. There
are three main factors which contribute to diabetic foot: neuropathy, ischemia, and
infection [8]. Twenty-five percent of diabetic individuals suffer from diabetic foot,
and 1 in 15 have problems necessitating amputation [5]. Presently, diabetic foot
is monitored strictly by visual and tactile observations. There is no quantitative
evaluation of ischemia that would enable more accurate monitoring and improved
care for patients suffering from diabetic foot.
These examples illustrate a few of the clinical situations that could benefit from
a non-invasive, inexpensive, quantitative, small, and accurate ischemia measure-
ment/detection device.
1.2 Previous Contributions
This project is part of an ongoing collaboration between Worcester Polytechnic In-
stitute (WPI) and the UMass Memorial Medical Center (UMMC). One manner in
which tissue viability and ischemia can be detected is by monitoring tissue pH. George
Gumbrell, a WPI M.S. student, developed and tested a device in clinical studies that
monitors tissue pH [9]. There are two drawbacks of the pH monitoring device, are
that invasive techniques are used (surgical implantation) and problems with stability
reduce the accuracy of the readings. Borislav Ristic´, a WPI Ph.D. student, developed
an ischemia monitoring device based on impedance spectroscopy and tested it on rab-
bits using needle electrodes [5]. Ristic´’s device relates tissue impedance parameters
to pH so that results are quantifiable and easy to understand. Ristic´’s experiments
with non-invasive electrodes were not successful. Analysis of his results led to an
investigation to determine a measuring methodology and the best electrodes for use
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in clinical situations where a non-invasive system is desirable. A measurement and
calibration protocol was developed and non-invasive electrodes were identified that
minimized the system’s noise and maximized the bandwidth [10]. Despite all of the
advancements towards the goal of developing a non-invasive ischemia detection de-
vice, a number of problems still need to be addressed. This thesis will focus on the
following problems:
Problem 1:
Measurements using impedance spectroscopy have been used to estimate skeletal mus-
cle ischemia in animal studies using needle electrodes. However, it has not yet been
proven effective for non-invasive ischemia monitoring of skeletal muscle in humans.
Problem 2:
Systematically and non-invasively recorded impedance spectra and simultaneous tis-
sue pH recordings during long term ischemia studies on humans are unavailable. Such
data is necessary to further develop an understanding of skeletal muscle response to
ischemia.
Problem 3:
Quantitative correlations between parameters of human tissue impedance spectra and
tissue pH have not been established. While testing different types of non-invasive
electrodes on human subjects it was observed that the relationship between the pa-
rameters of impedance spectra and pH, established during the animal studies, were
inadequate for human tissue analysis.
4
Chapter 2
Specific Aims
The long term goal of this research is to develop a non-invasive instrument for quan-
tifying human tissue ischemia based on impedance spectroscopy. Previously, a real
time continuous ischemia monitor was designed and tested on rabbit models. The
instrument and measurement methodology, however, were not developed for practi-
cal clinical applications. The project focused more on proving the basic principles
and hypotheses of the research and less on achieving fully accurate instantaneous
clinical ischemia measurements [5]. The present goal of this project is to solve the
most important problems that relate to the use of the instrument for practical clin-
ical applications. The aims of this Master’s thesis research are to conduct clinical
studies, collect data, and develop an algorithm based on artificial neural networks
that will estimate the tissue pH based upon real-time non-invasive tissue impedance
measurements. In more detail, the specific aims are:
• Prepare the instrument for clinical studies:
1. Identify and perform software and hardware modifications to ensure ability
to collect pH and impedance spectra (simultaneously) in a clinical envi-
ronment.
2. Determine appropriate pH electrodes and sterilization techniques, as well
as calibration procedures.
3. Make the instrument compatible with clinical and safety standards.
• Conduct clinical studies and collect data:
1. Develop a protocol for data collection.
2. Record pH and impedance spectra data from a minimum of 15 “bloodless”
surgeries conducted at the UMass Memorial Medical Center.
• Analyze the data:
1. Develop signal/data preprocessing (smoothing, filtering and data extrac-
tion) algorithms as necessary.
2. Determine the optimal set of impedance inputs for neural network analysis.
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3. Determine the type of neural network that will provide the best relation-
ship between predicted pH and actual pH based upon input impedance
parameters.
4. Train the neural network.
5. Test the neural network on data different from that which was used for
training.
The achievement of the above aims will result in a novel algorithm for muscular
tissue pH estimation based on impedance measurements and extraction of impedance
spectra parameters. This will constitute a significant advancement towards the goal of
developing a non-invasive real-time ischemia measurement device based on impedance
spectroscopy.
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Chapter 3
Hypotheses and Research
Approach
Tissue pH is highly correlated with levels of ischemia and tissue viability [11,12,13,14].
Thus, devices have been made that monitor levels of ischemia by directly determining
the tissue pH. Unfortunately, pH monitoring involves invasive procedures that require
the implantation of a pH probe into the tissue. In addition, such measurements only
effectively measure local pH values which are affected by the implantation and are
not necessarily representative of large regions of tissue. A device has been designed
to monitor ischemia based on the measurement of tissue impedance parameters [5].
This method, however, has only been utilized to monitor ischemia in rabbit muscular
tissue using invasive needle electrodes. During that study, a qualitative relationship
was determined between the parameters of impedance spectra and the pH in skeletal
muscle during ischemia.
3.1 Major Hypotheses
The central hypotheses of this research are that:
1. Bloodless extremity surgeries provide a good model for studying the effects of
ischemia on skeletal muscle tissue.
During bloodless surgeries a tourniquet is employed to cut off circulation to the
extremity and induces controlled ischemia.
2. Tissue ischemia can be monitored using non-invasive impedance measuring tech-
niques.
Our preliminary studies [10] indicate that with proper non-invasive electrodes
and calibration we can achieve impedance measurements with accuracies similar
to those seen using invasive techniques.
3. There is a stable and consistent relationship between pH and parameters of
impedance spectra of human skeletal muscle.
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This hypothesis is supported by the work done by Borislav Ristic´ where he
demonstrated a relationship between pH and impedance of rabbit skeletal mus-
cle using invasive techniques [5].
4. Artificial neural networks can be utilized to generate algorithms for estimating
the pH of the tissue based on parameters of tissue impedance spectra.
This hypothesis is supported by an abundance of literature on medical appli-
cations for artificial neural networks [15]. As well as by the success of Ristic´’s
work with animal models [5].
3.2 Research Approach
The hypotheses will be investigated and the aims evaluated by following a well defined
research approach. This research approach is illustrated in Figure 3.1 and explained
in detail below.
1. Explore relevant research: The first step is to determine what the previous
researchers in the fields of both impedance spectroscopy and pH monitoring
have accomplished. In addition, a general review of research relative to the
field of interest will be conducted.
2. Problem identification: Based on the research of previous investigators as well as
available literature, determine the specific problems that exist in the identified
field. Refer to Chapter 1 for a detailed explanation of the problem we hope to
address with this research.
3. Definition of aims: Evaluate the problems and decide which problems should
be addressed in the project and to what extent they should be pursued.
4. Develop a surgical model: Determine operative situations and protocols that
will be ideal for instrument evaluation and data collection (bloodless arm and leg
surgeries) through consultation with physicians/surgeons at the UMass Memo-
rial Medical Center (UMMC).
5. Ensure compatibility with clinical and safety standards: Modify software and
hardware to ensure ability to collect pH and impedance data simultaneously.
Gain approval from the Department of Clinical Engineering at UMMC to ensure
the electrical safety of the instrument in a clinical environment.
6. Determine and test appropriate pH electrodes: Test the desired electrodes in
vitro to determine appropriate calibration characteristics and determine the ap-
propriate sterilization techniques for the electrodes (consult with Central Sterile
at UMMC and electrode manufacturers).
7. Develop a protocol for data collection: Observe target surgeries and discuss
necessary instrument modifications for ease of use in the operating room (OR).
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8. Conduct clinical studies and collect data: Collect pH data and impedance spec-
tra from a minimum of 15 “bloodless” surgeries conducted at UMMC.
9. Determine inputs for neural network analysis: Use test data to evaluate possi-
ble parameters, then use clinical data to evaluate the performance of different
impedance parameters and the overall effectiveness of the neural network.
10. Determine neural network type: Determine the appropriate number of hidden
layers and the appropriate transfer functions to optimize neural network output.
Train the neural networks with a sample set of data, then evaluate the neural
networks using clinical data to determine which neural network will provide the
best relationship between estimated pH and actual pH.
11. Update the algorithm for pH extraction based on neural network results.
Following this research approach, the hypotheses and aims of this work will be
investigated. The research approach has numerous feedback paths, some of which
are identified in Figure 3.1. These paths enable use to use a dynamic process where
procedures and data analysis can be modified to satisfy the demands of the clinical
environment.
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Problem Identification
Development of a Surgical Model
Software/Hardware Modifications
for Clinical & Safety Requirements
Determine & Test Appropriate
pH Electrodes
Develop Protocol for Data Collection
Patient Testing
Testing Design Improvements
Determine Inputs for Neural Networks
Determine Neural Network Design
Train and Evaluate Neural Network
Update pH Estimation Algorithm
Explore Relevent Literature
Figure 3.1: Flowchart of research approach. The basic approach is
illustrated as are some of the numerous feedback loops.
For a more detailed explanation of the research approach
please refer to Section 3.2.
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Chapter 4
Background
In order to better understand the research problem, a number of areas need to be
investigated. These areas include the electrical and physiological properties of bio-
logical tissue, impedance spectroscopy, ischemia, ischemia detection techniques, pH,
and artificial neural networks.
4.1 Tissue Ischemia
The goal of this project is to develop an instrument to non-invasively determine the
level of ischemia in human skeletal muscle. It is, therefore, important to have a
complete understanding of what ischemia is and how it affects biological tissue and
its properties.
Ischemia is a condition of reduced oxygen and nutrient supply to the tissue due
to the constriction or obstruction of blood vessels. Ischemia forces the tissue to
function under anaerobic conditions. The most well known forms of ischemia are
ischemia of the heart (heart attack) and ischemia of the brain (stroke), however, all
normally perfused tissues can become ischemic. Different tissues respond differently to
ischemia. Skeletal muscle can survive for a relatively long period of time in anaerobic
conditions. Myocardial muscle, however, can survive for only a few moments, and
the brain begins to die almost immediately. Our research focuses on ischemia in
skeletal muscle. Skeletal muscle ischemia was chosen for evaluation because skeletal
muscle is easily accessible, it can endure short periods of ischemia without causing
permanent injury, and its ischemia represents a clinical problem. We will observe the
effects of ischemia during “bloodless” surgeries where, during the normal procedure,
a tourniquet is inflated on the upper portion of the limb causing reduced blood flow
and ischemia in the limb allowing the surgeon to perform delicate work in a bloodless
field.
The tissue undergoes a number of metabolic changes during ischemia and anaer-
obic metabolism. In non-ischemic tissue, skeletal muscle primarily uses aerobic res-
piration where glucose is broken down into pyruvic acid and then, with O2 present,
is converted into ATP in the mitochondria with CO2 as a by product. The CO2 is
then removed by the circulation of blood. During ischemia, there is a decrease in the
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Metabolite Change due to Ischemia
Lactate Increases
pO2 Decreases
Potassium Moves into extracellular fluid
pH Decreases
pCO2 Increases
Sodium Moves into intracellular fluid
Pyruvate Increases
Table 4.1: Metabolite changes due to ischemia. Of special inter-
est in this study is the decrease of pH. Also, the sodium
shift from intracellular to extracellular leads to a shift
of fluid volume from extracellular to intracellular (this is
important in the later evaluation of electrical properties
of tissue during ischemia as discussed in Section 4.2.3).
oxygen (pO2 ↓) and glucose available to the tissue as well as a decrease in the removal
of carbon dioxide (pCO2 ↑) from the tissue due to inadequate blood-flow. As a result
of the decrease in pO2, the muscle employs an anaerobic metabolic pathway. In this
process glucose is broken down into pyruvic acid and then converted into lactic acid
and some ATP (less ATP is provided than with aerobic respiration) [16]. This leads
to a buildup of lactic acid which causes a decrease in the tissue pH.
Normally, when cells are at rest, they are not passive, but in an active state where
the physiological concentrations of molecules are maintained inside and outside of the
cell through the action of ion pumps [17]. This process requires ATP which is limited
during ischemia causing the ion pumps to fail. When the ion pumps fail, intracellular
and extracellular concentrations of important small molecules such as sodium (Na+),
potassium (K+) and chloride (Cl−) shift, leading to abnormal ion buildups within
the cells. The change in metabolites caused by ischemia are summarized in Table 4.1.
4.2 The Electrical Properties of Tissue
Electrical events are integral to the function of healthy, living tissues. Everything
from the beating of the heart to nerve impulses are based on electrical phenomena.
Our work focuses on measuring the macroscopic electrical properties of tissue by
applying stimuli that do not interfere with cell polarization, and are of low intensity,
ensuring that the linear properties of the tissue are maintained.
4.2.1 Electrical Properties of Healthy Tissue
There are many differences between the electrical properties of biological tissues and
the electrical properties of physical electronic circuits. The first major difference
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is that in biological tissues, ions are the main current carriers whereas in electrical
circuits the current results from the movement of electrons. Since ions are the major
charge carriers, the conductivity of biological tissue is highly dependent on factors
such as concentrations, effective charge, diffusion coefficients, and the types of ions
involved in the process [18]. In an electrical circuit, the current density does not
affect the properties of the circuit (unless self heating becomes a problem, J > 100−
1000A/cm2), and passive electrical circuits always obey Ohm’s Law. The linearity
of the tissue properties is considered to hold as long as the current injected doesn’t
exceed 1mA/cm2 (this value is frequency dependent) [19]. In this project, only the
electrical properties of the tissue measured with a passive non-stimulating current
will be investigated.
Despite the differences between the electrical properties of biological tissues and
those of electrical circuits, circuit models can be used to describe the electrical prop-
erties of biological tissue. The most common descriptors of the electrical properties
of biological tissue are complex impedance (Z) and dielectric properties (complex
permittivity, εˆ) as described in Equation 4.1 and Equation 4.2.
Impedance:
Z = R + jX
R = Re{Z} = resistance of tissue,
X = Im{Z} = reactance of tissue,
j =
√−1
(4.1)
The impedance of biological tissue results from the interaction of an electrical
current with the tissue at the cellular and molecular level. The dielectric properties
of biological tissue are the result of the interaction of electromagnetic radiation with
the tissue at the cellular and molecular level [20]. Complex electrical impedance
measurements are better suited to defining the electrical behavior on the macroscopic
scale than evaluations of the dielectric properties of the tissue [21]. Thus, for our
work, we will focus on the complex electrical impedance.
Permittivity:
εˆ = ε′ + jε′′
ε′ = relative permittivity of tissue,
ε′′ = out-of-phase loss factor.
(4.2)
The electrical behavior of biological tissues can be modeled with a series of nested
RC circuits where C is a pseudo-capacitance and is represented by a special constant
phase element as discussed by Cole & Cole [18]. It is referred to as a series of nested
RC circuits because of the intricacies of biological tissue at a molecular level. The
equivalent circuit is illustrated in Figure 4.1. The electrical resistance of the extra-
cellular space is modeled by the parallel resistance Rex. This resistance is equivalent
to the resistance measured at zero frequency denoted as R0. The resistance of the
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Figure 4.1: Electrical model of biological tissue where Rex represents
the resistance of the extracellular space, Rin represents
the resistance of the intracellular space and C represents
the membrane pseudo-capacitance.
intracellular space is represented by the Rin. The membrane pseudo-capacitance is
represented by the constant phase element C. At high frequencies the resistance of
the tissue can be defined as the parallel combination of Rex and Rin and is denoted
as R∞.
Based on the circuit diagram and the Cole equation, the impedance can be deter-
mined [18] as illustrated in Equation 4.3.
Z = R∞ +
R0 −R∞
1 + (jωτ)α
ω = 2pif = angular measurement frequency
τ = characteristic time constant
α = empirical dimensionless constant from 0-1
(4.3)
One way in which to visualize the impedance data is by plotting the resistance
against the negative reactance to obtain a Nyquist locus. As illustrated in Figure 4.2
the result is a semi-circle with a depressed center. In most electrical circuits α is equal
to one, with the resulting center point of the locus lying on the real axis. When α = 1,
C as illustrated in Figure 4.1 acts strictly as a capacitance. In biological tissue α is
less than one, typically 0.85, leading to the depression of the center of the locus below
the real axis. In these cases C no longer behaves strictly as a capacitance and behaves
as a pseudo-capacitance. The depressed locus is the result of the contributions of the
capacitive properties of the cell membranes.
In addition to visualizing impedance data with Nyquist plots, which allow both
the resistance and reactance to be viewed in one plot, the resistance and reactance
curves can be viewed separately. Figure 4.3 illustrates the resistance plotted against
the logarithm of the frequency from 10Hz to 10MHz. The reactance can be plotted
similarly and is illustrated in Figure 4.4.
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Figure 4.2: A typical Nyquist plot with the negative tissue reactance
−Im{Z} plotted against the tissue resistance Re{Z}.
R0 refers to the resistance measured at 0 frequency.
R∞ refers to the resistance at very high frequencies.
Z(ω)refers to the impedance as a function of frequency
and |Z(ω)| refers to the magnitude of the impedance.
α(pi/2) is related to the depression of the center of the
locus.
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Figure 4.3: A typical plot of tissue resistance Re{Z} against fre-
quency using the electrical model illustrated in Fig-
ure 4.1. R0 refers to the resistance measured at 0 fre-
quency. R∞ refers to the resistance at very high fre-
quencies. The central dispersion frequency is illustrated.
Please note that this is for the β dispersion region.
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Figure 4.5: Typical dispersion regions for biological tissue. The
α dispersion region below 1kHz, the β region between
10kHz and 50kHz and the γ region above 100MHz.
In Figure 4.3 of tissue resistance vs. frequency, there is a region where the resis-
tance changes dramatically over a small range of frequencies. This area, corresponding
to a fast change in the tissue impedance, is known as a dispersion region. By expand-
ing the frequency range, three distinct dispersion regions can be observed in biological
tissue both in tissue impedance measurements and in measurements of the dielectric
constant [22]. Figure 4.5 illustrates the three dispersion regions: α, β, and γ.
α - The first dispersion region is in the low frequencies, typically below 1kHz and
often at frequencies less than 10Hz. The change in impedance in this region is as little
as 1-2% and is the result of surface conductances, ion gates, and cell membranes.
β - The second dispersion region typically falls between 10kHz and 50kHz for
muscular tissue and happens mostly due to the phenomenon of the cell membrane.
There are two major contributing factors to the β dispersion, the shorting out of the
membrane capacitances and the rotational relaxation of biomacromolecules [23].
γ - The third dispersion region is usually at very high frequencies (above 100MHz).
This dispersion is caused by the sub-cellular components of the tissue and the water
relaxation of the tissue.
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Figure 4.6: The electrical model of the electrode-electrolyte inter-
face. E represents the half-cell potential. The R1 and C
parallel combination represent the electrode-electrolyte
interface and R2 represents the electrolyte resistance.
4.2.2 Characteristics of the Skin-Electrode Interface
For non-invasive tissue impedance measurements ECG electrodes consisting of a metal
electrode and an electrolyte gel that is affixed to the skin are used. Due to the ECG
electrode construction we need to address the electrode-electrolyte interface as well as
the electrolyte-skin interface properties and examine their potential influences on the
results of our research. These two interfaces combined are considered to be the skin-
electrode interface. There are three major factors that affect the overall skin-electrode
interface: offset potentials, polarization impedance and skin impedance.
The electrode-electrolyte interface can be modeled with four electrical compo-
nents: two resistances, a capacitance, and a half-cell potential (Figure 4.6) [24]. At
the electrode-electrolyte interface the two major causes of measurement inaccuracy
are offset potentials and the polarization impedance. When using electrodes of iden-
tical composition and manufacture the offset potential should ideally be zero. This is
rarely the case because conditions such as surface irregularities and electrolyte con-
taminants cause potential differences ranging from microvolts to millivolts. This can
cause problems during AC impedance measurements because the offset potentials can
be large, unstable, and may overpower the desired signal [18].
Polarization impedance results when an alternating current is passed through the
electrode-electrolyte interface modulating the offset potential. This induces chemical
reactions that cause changes in the impedance of the electrode-electrolyte interface.
Although offset potentials and the polarization impedance are important factors
in the overall skin-electrode interface, the most influential factor is the impedance of
the skin. The typical electrical model for the skin is a resistor in series with a parallel
combination of a resistor and a capacitor (Figure 4.7).
The impedance of the skin varies depending upon anatomical position due to the
differences in sweat gland activity, thickness of the skin, moisture content of the skin,
and other related phenomenon. Two tissue layers characterize the electrical properties
of the skin: the epidermis and the dermis. The epidermis primarily determines the
impedance at frequencies below 100Hz. Above 100Hz, the capacitive properties of
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Figure 4.7: Electrical model of the skin. The parallel combination
of R1 and C represent the epidermis and RIN represents
the dermis.
the epidermis get shorted out (the epidermal reactance decreases) and the dermis
becomes the dominant source of the impedance at frequencies higher than 10kHz.
Due to this phenomena, the impedance of the skin decreases as frequency increases.
4.2.3 Electrical Characteristics of Ischemic Tissue
In order to determine the frequency range in which measurements should be recorded,
the electrical properties of healthy skeletal muscle as well as the properties of the
electrode-skin interface are considered. Additionally, the electrical properties of is-
chemic tissue are considered.
Most early research was conducted in the β dispersion frequency range because
instruments were not available to thoroughly investigate the α and γ region. Later
research heavily explored healthy tissue responses in those regions. The behavior of
ischemic tissue in the α, β, and γ regions has been explored [19] and the following
conclusions were made [5]:
• During ischemia there is a shift in fluid volume from the extracellular spaces to
intracellular spaces. This leads to increases in impedance at the low frequencies
due to the capacitive nature of the cell membranes. Thus, there is an increase
in impedance in the α and β dispersion regions due to ischemia.
• The impedance at high frequencies (in or around the γ region) is relatively
unaffected by ischemia, tissue excision, and tissue death. This is largely due
to the fact that the existence of cellular membranes does not affect the high
frequency measurements.
• The α dispersion breaks down much more quickly than the β dispersion (typi-
cally within a few hours after the onset of ischemia). The α dispersion reacts
to environmental factors and various physiological processes as a consequence
of many different relaxation mechanisms.
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Based on the above evaluations of the three different dispersion regions, it was
decided that the β region would be the most suitable for investigating the electrical
properties of ischemic tissue and obtaining accurate measurements.
A more detailed review of the effects of tissue ischemia in muscular tissue within
the β dispersion region follows. It has been shown that ischemia causes the resistivity
of muscle tissue to increase by as much as 30% almost immediately [5, 25] after the
onset of ischemia. The main reason for this increase in resistivity is the swelling of
the cells which leads to a decreased extracellular volume. This increase is primarily
manifested at the low frequencies because low frequency current cannot penetrate
the cell membrane. A number of studies demonstrate the increase in tissue resistivity
for up to 8 hours after the onset of ischemia before resistivity decreases due to the
breakdown of the cellular membranes [5, 25, 26, 27].
4.2.4 Electrical Properties and Anisotropy
Anatomically and physiologically, skeletal muscle is highly anisotropic. To evaluate
the anisotropic nature of muscular tissue, the properties of tissue at low frequencies
and the properties of tissue at high frequencies must be evaluated. At low frequencies,
the electrical properties of skeletal muscle are highly anisotropic - the transverse
impedance of muscle is much higher than that of the longitudinal impedance [28].
At high frequencies, anisotropy is less evident because the cell membranes are short-
circuited so the tissue impedance is relatively independent of tissue orientation and
is essentially equal to the impedance of the cytoplasm [29]. In order to minimize the
effect of anisotropy on measurements of electrical properties of tissues, it is necessary
to use modeling techniques to decouple the sample geometry from the measured tissue
resistivity [30].
4.3 Techniques for Tissue Ischemia Monitoring
There are a number of different techniques for monitoring tissue perfusion/ischemia,
but none of them fit the criteria of an “ideal” ischemia monitor. According to Dunn [1]
an ideal ischemia monitor should comply with the twelve criteria listed in Table 4.2.
A comparative analysis of different ischemia measurement techniques is illustrated in
Table 4.2.
The basic principles of each measurement technique were reviewed and a summary
of the principles behind each technique are stated below [5]:
I. Doppler Monitoring
Doppler monitoring is based on the principle that sound changes frequency when
reflected off of moving objects, in this case, red blood cells. A miniature Doppler
probe is surgically implanted around the artery supplying blood to the affected
tissue and then blood flow to the tissue is monitored. The drawbacks of this
monitoring method are that it requires a tricky surgical procedure to implant
the probe and the probe can sometimes occlude the artery inducing ischemia.
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Ideal Ischemia Monitor Characteristics
1. Non-invasive 2. Harmless to the tissue
3. Accurate and reliable (sensitive/specific) 4. Able to provide rapid response
5. Simple (capable of being used by personnel) 6. Applicable to surface & buried tissues
7. Capable of continuous and/or discrete readings 8. Objective (quantifiable)
9. Sensitive to arterial vs. venous compromise 10. Inexpensive
11. Stable during long studies (a few days) 12. Portable
Measurement Principle Ideal Monitor Characteristic #
1 2 3 4 5 6 7 8 9 10 11 12
I. Doppler Monitoring
√ √ √ √ √ √ √
II. Laser Doppler
√ √ √ √ √ √
III. Fluorescin Staining
√ • • √ √
IV. Transcutaneous pO2
√ • √ • √ √ √ √ √
V. Transcutaneous pCO2
√ • √ • √ √ √ √ √
VI. pH Measurements • √ √ √ • √ √ • √ • √
VII. Duplex Scanning
√ √ • √ √ √ √
VIII. Angioscopy
√ √ √ √
IX. Arteriography
√ √ √ √
X. Impedance Measurements • √ • √ • √ √
XI. Impedance Spectroscopy
√ √ √ √ √ • √ √ √ √ √
XII. MRI Diffusion Mapping
√ √ √ √ √ √
Table 4.2: Characteristics of ischemia measurement techniques [5].
The
√
refers to a fully satisfied requirement, • refers to
a partially satisfied requirement and a blank space refers
to an unfulfilled requirement.
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II. Laser Doppler
Laser Doppler monitoring is a non-invasive procedure where a laser is used to
monitor blood-flow in the capillary bed of the tissue. The drawback to this
method is that the flow can only be measured to a depth of 1 to 2 mm.
III. Fluorescin Staining
In fluorescin staining, the patient is injected with fluorescin dye. Within approx-
imately thirty seconds the dye moves to all of the perfused portions of the body.
The body is then exposed to ultraviolet light which causes the fluorescin to emit
a fluorescent light. Areas that were not well perfused will exhibit a low level
of emitted light. Some limitations of this system are that it is not continuous,
quantitative, or easy to implement.
IV. Transcutaneous pO2
Transcutaneous pO2 measurements non-invasively measure the partial pressure
of oxygen in subcutaneous tissue. This method is a very sensitive indicator
of ischemia, but it cannot be used for continuous long term monitoring and it
requires access to healthy skin sections for proper placement and measurement.
V. Transcutaneous pCO2
Transcutaneous pCO2 measurements non-invasively measure the partial pressure
of carbon dioxide in subcutaneous tissue. A drawback to this method is that
the measuring electrodes typically must be heated in order to assure proper
performance making it necessary to carefully monitor electrode placement in
order to prevent tissue damage.
VI. pH Measurements
pH Measurements require the implantation of a pH microelectrode in the tissue
of interest and the results give a measure of how ischemic the tissue is. This
method is good for long term monitoring with the drawback being the invasive
nature of the procedure.
VII. Duplex Scanning
Duplex scanning uses an ultrasound Doppler device that incorporates a B-mode
ultrasound imager. The imager locates the desired vessel, and then the ultra-
sound Doppler measures the blood flow. This procedure is non-invasive but
suffers from many of the drawbacks of Doppler monitoring.
VIII. Angioscopy
Angioscopy is an endoscopic procedure where a thin fiber is inserted into the
vessel and the structures of the vessel can be observed. This method provides
a valuable insight into the tissue, but is quite invasive and cannot be used for
continuous monitoring.
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IX. Arteriography
Arteriography is an X-ray imaging technique where a contrast material is in-
jected into the blood stream and its flow patterns are observed and recorded.
This technique is invasive, requires cumbersome equipment, and cannot be used
for long-term continuous monitoring.
X. Impedance Measurements
Single frequency impedance measurements have been used to monitor ischemia.
There are two major drawbacks to these systems. The first is the use of invasive
electrodes for measurements. The second is that single frequency trends in
measured impedance can be detected but absolute measures of ischemia cannot
be determined. This because a large number of parameters affect the single
frequency tissue impedance.
XI. Impedance Spectroscopy
The principles behind impedance spectroscopy will be explained in detail in
Section 4.5.
XII. MRI Diffusion Mapping
Magnetic resonance imaging is a powerful tool for detecting ischemia. The
advantage to this method is that it can image any tissue regardless of location
within the body. The disadvantage is that it is very expensive, it is not portable,
and it has limited accessibility.
4.4 Impedance Measurements in Medicine
Electrical impedance measurements have been used in biological studies since the
early 1800s. More recently, impedance measurements have been used in a num-
ber of applications such as impedance plethysmography, impedance tomography, and
impedance cardiography. In impedance plethysmography, the electrical impedance is
measured and used to determine the amount of fluid in the pleural cavities. Imped-
ance plethysmography has also been used to detect deep vein thrombosis. Impedance
plethysmography was the first use of impedance measurements in medicine. Imped-
ance tomography is a method of imaging tissue in which a series of electrodes are
attached in a single plane to the chest or breast of the patient. An image of the tissue
is then constructed based on the impedance information. For a more complete listing
of impedance techniques in medicine please refer to [31].
4.5 Impedance Spectroscopy
As discussed in Section 4.3, our work focuses on the use of impedance spectroscopy
to monitor tissue ischemia. In order to understand the ischemia monitor that we are
using for clinical experiments, the basic principles behind impedance spectroscopy
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must be reviewed. The specific hardware and software controls for the instrument
used in this study will also be presented.
4.5.1 Definition and Principles
Impedance spectroscopy is the measurement of complex impedance over a range of
frequencies. The impedance is determined by injecting a subthreshold current (typi-
cally less than 1mA/cm2) into the desired tissue, and recording the resultant voltage.
There are two basic techniques for measuring the impedance of biologic tissue: the
bridge and the phase sensitive detector methods [5]. Additionally, the bridge and
phase sensitive detector methods can each be done using either a two-electrode or
four-electrode method.
The bridge method traditionally has been the most popular method for ischemia
measurements. There are a number of disadvantages to this system. This method is
time consuming and in commercial models often lacks sufficient accuracy for phase
measurements in biological tissue [18]. Measurement accuracy is also poor at low
frequencies.
The phase sensitive detector utilizes a constant current source and a lock-in ampli-
fier or software demodulation that provides for the rapid acquisition of measurements,
which is useful in biological systems [18]. The phase sensitive detector has many ad-
vantages: [5]:
• Accurate measurements throughout the frequency range.
• Fast automated measurements.
• Simplicity of design and operation.
Both the bridge method and the phase sensitive method can be used with either
a two-electrode measurement system, or a four electrode measurement system. With
the two-electrode measurement system, current is injected through the two electrodes
and voltage is measured on the same electrodes. The impedance is then determined
by dividing the measured voltage by the injected current. The disadvantage of the
two-electrode system is that the current density at the injection site may be higher
than the threshold for linear behavior. This causes the measured impedance of the
tissue to weigh more heavily near the electrodes than elsewhere in the tissue [32].
Also, because the skin-electrode impedance is in series with the tissue impedance,
the two impedances cannot be separated. Current flow through the measurement
electrodes is higher with the two-electrode measurement system than with the four
electrode measurement system. This high electrode current can cause high skin-
electrode impedance with the two electrode system.
The four-electrode method is the method used in this research. For this method,
the two outer electrodes are used to inject the current into the tissue. The injected
current then forms equipotential surfaces within the tissue (Figure 4.8). The inner
electrodes then measure the resultant voltage. The measured tissue impedance is
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Figure 4.8: Four-electrode measurement system. In this system the
current is injected into the tissue through the outer spot
electrodes and the resultant voltage is recorded from
the inner electrodes. Based on the known current and
the recorded voltage the tissue impedance can be deter-
mined.
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then calculated as:
Z =
VIN+ − VIN−
IOUT
(4.4)
The variables refer to the recorded voltage and the output current as illustrated
in Figure 4.9. Due to the separate positioning of the electrodes, the current den-
sity where the voltage is measured is mostly uniform and well below the 1mA/cm2
threshold for linearity, so the measurements are more accurate. Also, the measured
impedance does not include the skin or electrode-electrolyte impedance.
4.5.2 Hardware and Software Design
The impedance spectrometer is an extremely useful and precise tool for measuring
complex tissue impedance. Many manufacturers have built impedance spectrometers
that are suitable for either very large or very small impedance measurements. How-
ever, none of the manufactured spectrometers were suitable for this clinical study
due to large expenses and inability to custom fit the hardware and software of the
system. In a previous impedance spectroscopic investigation, Borislav Rist´ic, a Ph.D.
student from Worcester Polytechnic Institute, built an instrument that was capable
of measuring tissue impedance in a frequency range from 10Hz to 1MHz [5]. The
impedance spectrometer is connected to an IBM compatible computer which controls
the operation of the instrument.
Software (using National Instruments Lab Windows/CVI) was developed by Rist´ic
in order to control measurements and process and store data collected during testing.
It is capable of graphically representing both impedance and pH measurements.
The impedance spectrometer attaches to the IBM compatible computer via the
parallel port, which sets operational functions in order to obtain measurements. A
basic block diagram of the instrument is illustrated in Figure 4.9. The basic starting
functions performed by the PC for each frequency sweep are [5]:
1. Select Frequency: The PC selects the output current frequency and the A/D’s
sampling frequency from a table of chosen frequencies.
2. Measure Voltage:
i. Select zero output current frequency in order to turn off the current source
and preset the measurement system into a starting state.
ii. Program the multiplexer to output the voltages from the signal acquisition.
iii. Set the amplification of the input voltage signal.
iv. Program the data acquisition module with the A/D conversion sampling
frequency.
v. Acquire the input voltage data.
3. Repeat Step 2 a total of 128 times.
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Figure 4.9: A block diagram of the impedance spectrometer [5]. Iout
refers to the current output from the instrument and in-
jected into the tissue. VIN refers to the voltage recorded
from the tissue. The unit physically consists of three
parts. The electrode assembly (electrodes and cable con-
figuration), the impedance spectrometer (current mea-
surement, multiplexor, current source, data acquisition,
and communication modules) and the laptop that con-
trols the impedance spectrometer.
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4. Find the average standard deviation, σ.
5. Measure the current:
i. Initiate the current source: The output current of the selected frequency is
written into the current source’s input register.
ii. Program the multiplexer to output the current.
iii. Program the amplifier with the gain of the output current signal.
iv. Output the desired current.
6. Repeat Step 5 a total of 128 times.
7. Find the average standard deviation, σ.
8. Repeat steps 1 through 7 for each of the desired frequencies.
9. Software demodulation: calculate resistance and reactance.
10. Extract Cole-Cole parameters
11. Extract parameters for artificial neural networks.
Sampling will always begin at the same phase due to the resetting of the system
in step 2. The impedance spectrometer performs A/D conversion and data is then
sent to the computer to be processed. When the computer is finished reading the
data, a signal is sent back to the impedance spectrometer to initiate the next sample
acquisition and the computer waits for the end of the next A/D conversion. For this
project, 95 frequencies ranging from 10Hz to 1MHz are specified within the software.
At each frequency 128 averages are performed and one sweep through all of the
frequencies takes a minute and a half.
The impedance spectrometer creates and measures excitation currents as well as
preprocesses and digitizes the measured voltage and current signals. The data is then
sent to the PC via the signals described above. The block diagram of the instrument
is illustrated in Figure 4.9. The spectrometer is attached to an electrode assembly
module with a 50cm long multi-lead cable as shown in Figure 4.10. This module
contains lead wires that attach to a set of four ECG electrodes. The outer pair of
electrodes are used for injecting excitation current and the inner pair of electrodes
are used for measuring the resultant voltage (Figure 4.8).
Calibration of the instrument is performed in order to be certain that the system
is working properly, as well as to compensate for amplitude and phase variations of
the instrument over the measurement frequencies and selected gains. The imped-
ance spectrometer measures both the input voltage and output current, which are
expressed in A/D converter units. Calibration determines the proportionality coef-
ficient between sampled and real values of the input voltage and output current [5].
These coefficients vary slightly at different measurement frequencies due to signal
variations in the measurement system. Two important calibration coefficients used
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Figure 4.10: Detailed diagram of the electrode assembly and its con-
nection to the impedance spectrometer(IS) [5]. Iout
refers to the current output from the instrument and in-
jected into the tissue. Vin refers to the voltage recorded
from the tissue. The electrode assembly further con-
sists of an instrumentation amplifier and a cable with
a driven shield.
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to improve system performance are the voltage gain (Cgain,ω) and the phase gain
(θgain,ω) at each frequency. Equations 4.5 and 4.6 give the estimated impedance once
the coefficients have been determined. Errors occur from gain nonlinearity, CMR,
and large loads at high frequencies, all of which sum up to an actual or total error.
Calibration reduces this error [5].
Impedance Magnitude:
|Z(ω)| = Cgain,ω · |Zmeasured(ω)|
= Cgain,ω · |V (ω)||I(ω)|
Z(ω) = Estimated Impedance
Zmeasured(ω) = Impedance calculated as V/I
(4.5)
Impedance Phase:
arg(Z(ω)) = arg(Zmeasured(ω)) + θgain,ω
= arg(V (ω))− arg(I(ω)) + θgain,ω
V (ω) = measured input voltage
I(ω) = measured output current
(4.6)
4.6 pH Principles and Measurement
4.6.1 Definition and Principles
pH is a basic measure of the acidity of a substance. It was first defined by Sorenson
in 1909. According to him, pH was strictly defined as the “hydrogen ion exponent
and the written expression PH . By the hydrogen ion exponent (PH) of a solution
we understand the Briggs logarithm of the reciprocal value of the normality factor
of the solution based on the hydrogen ions” [33]. This definition is mathematically
represented by:
pH = −log[H+] (4.7)
The pH scale ranges from 0 to 14 with lower values indicating a more acidic
substance. When the number of [H+] ions in the substance increases the pH decreases
and conversely, when the number of [OH−] ions increases the pH increases.
pH is a familiar measure to people both in the scientific and medical communities.
Because of this familiarity, pH is an ideal parameter by which to describe ischemia in a
clinical situation. There are many different measurement techniques for determining
the level of pH, ranging from Litmus Paper tests to expensive commercially available
pH meters. For our work we will utilize a pH meter.
A pH meter consists of three parts: a measuring electrode, a reference electrode,
and a high input impedance meter [34]. The measuring electrode that we are using is a
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glass electrode, specifically, a MI-508 Flexible pH Electrode from Microelectrodes, Inc.
For calibration we are using a MI-402 Micro-Reference Electrode with flexible barrel
from Microelectrodes, Inc. During clinical procedures a disposable ECG electrode is
used as the reference. For the clinical trials we are using a pH meter designed by
George Gumbrell [9] and described in detail in Section 4.6.3.
Glass electrodes consist of thin glass bulbs with a silver electrode mounted inside.
The silver electrode is immersed in a solution of constant pH, containing ions to
which the electrode is permeable. When the glass electrode is immersed in a solution,
a potential develops across the surface of the glass membrane. This potential varies
as the ion concentration varies. In order to determine a quantitative assessment of
the change in ion concentration, a reference electrode is necessary. The potential
difference between the glass electrode and the reference electrode is then recorded
in millivolts and converted to a pH value based on calibration constants [35]. The
calibration constants can be calculated based on the recorded potentials and the
actual pH values collected during calibration. The calibration constants for slope and
intercept are calculated in Equations 4.8 and 4.9.
Slope(s):
s = − E1 − E2
pH1 − pH2
E1 = Voltage of a solution of pH1
E2 = Voltage of a solution of pH2
(4.8)
Intercept:
E ′ =
E1 − s · pH1
T
T = Temperature in Kelvin
(4.9)
Once the calibration constants have been determined, the pH of any given solution
can be determined using Equation 4.10.
pH =
E −∆Elj − E ′ · T
−s
E = Measured potential of solution
∆Elj = difference between the potential of the buffers and solution
(4.10)
According to Equation 4.10 there are two major possible sources of error. The
first is temperature and the second is the ∆Elj which is caused by the difference in
liquid junction potentials between the buffers and the measured solution. For our
application T is known and fairly constant (temperature of the human body). ∆Elj
is high when the medium being measured has a higher ionic strength than the buffers
used. The effects of ∆Elj can be minimized by ensuring that the electrode is clean
before each use.
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4.6.2 pH Changes During Ischemia
Much work has been done concerning the changes in pH as a result of ischemic events
in different parts of the body, however, for this research only the changes in skeletal
muscle are evaluated. As mentioned in Section 4.1, it is universally known that
pH decreases as the tissue becomes more ischemic. The rate of change of pH as a
function of ischemia has also been evaluated in a number of situations. Canine hind
limbs subjected to a total of three hours tourniquet time exhibited an average pH
change of 7.08 to 6.35 or 0.73 pH units (-0.0041pH units/minute) measured using
31P NMR [36]. Rat anterior thigh flaps have been subjected to arterial, venous, and
combined occlusions and the change in tissue pH was monitored using pH micro-
electrode [13]. Arterial occlusion produced a drop of 0.66 units at hour 1 (-0.011pH
units/minute), venous occlusion produced a drop of 0.27pH units at hour 1 (-0.0045pH
units/minute) and the combined group had a drop of 0.55pH units at hour 1 (-0.0092
pH units/minute) [13]. Note that the per minute values are averaged and that for the
rat experiment it was noted that there was a rapid drop of pH immediately following
occlusion and the rate of decrease declined thereafter.
Another study evaluating the tissue pH of skeletal muscle in an amputated rat
hind limb observed a change of 0.80pH units over the course of 240 minutes (0.0033pH
units/minute) [37]. The change of pH in rabbit hind legs as a result of ischemia has
also been evaluated. After the occlusion of the femoral artery, tissue pH in the
rabbit hind limb decreased from 7.4 to 7.05 over the course of an hour (-0.0058 pH
units/minute) as measured with a pH micro-electrode [38]. In prior work with this
instrument and rabbit hind limbs, an average decline in tissue pH of -0.00677pH
units/minute [5] was reported. As the examples above indicate there is a marked
change in skeletal muscle pH in time with an average per minute change ranging
from -0.0033pH units to -0.011pH units depending upon the experimental model. It
is important to note that a Medline search using the keywords ischemia, pH and
skeletal muscle did not reveal any articles dealing with pH changes during ischemia
in human subjects.
4.6.3 Hardware and Software
The hardware and software for the pH monitor were originally developed by George
Gumbrell, M.S. [9]. The hardware converted the analog pH signal into digital form
and provided an interface between the laptop computer and the pH electrodes. A
block diagram of the hardware for the pH meter is located in Figure 4.11.
The software initially sends out control signals to select the appropriate pH and
reference channels, then the DC signal enters the buffer stage where current gain
occurs. The signal then passes through the amplification and filtering stages before
reading the A/D converter where it is converted into a digital signal. The digital
signal passes through isolation (for patient protection) before being sent to the laptop
computer. The software on the laptop computer then converts the digital signal to
a pH value according to Equation 4.10. The software that was used to control the
hardware was modified by Borislav Rist´ic [5] and Susan Shorrock [35] in order to allow
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Figure 4.11: Hardware configuration for the pH meter. For a de-
tailed description of the hardware setup refer to Sec-
tion 4.6.3.
it to run simultaneously with the impedance software and for improved calibration
respectively. For more information on the software please refer to Chapters 5 and 6.
4.7 Artificial Neural Networks
For clinical purposes, the impedance spectrometer must transcend the measured tis-
sue impedances to pH values in order to make data palpable to hospital staff. The
relationship between pH and impedance is nonlinear and has not been previously
established. One of the fundamental hypotheses of this project is that a knowledge-
based classifier such as a neural network will be able to reproduce this relationship
reliably. In the remainder of this section, three basic neural network types will be dis-
cussed: the Hebbian, the ADALINE, genetic, and backpropagation neural networks.
The Hebbian neural network is a simple network and consists of a Hamming neural
network that employs the Hebb learning Rule. This neural network consists of a feed
forward layer and a competitive layer (Figure 4.12) [39]. The Hebb Rule is then
used where the synaptic weight is a function of both the presynaptic and postsynaptic
activities [40]. In this type of network the output is equal to a bias vector plus the
input multiplied by a weight matrix. This output is then sent to the competitive
layer where a winner is determined, resulting in a single discrete output [39].
The ADALINE or ADAptive LINear Element neural network is also a simple linear
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Figure 4.12: The Hebbian neural network. R refers to the number
of inputs to the input layer. S refers to the number of
neurons in the output layer. P is the matrix of input
vectors(R × the number of training pairs). W is the
weight matrix and b refers to the bias vector. n is the
matrix of values output from he first layer of neurons.
f refers to the transfer function. c represents the com-
petitive layer. a indicates the matrix of output vectors.
neural network [41]. This type of neural network has one layer of neurons and uses
a linear training function (Figure 4.13). The ADALINE is trained using the Delta
Rule, also known as the least mean square algorithm. The objective of the adaptive
process in the ADALINE neural network is to find the optimum set of input patterns
and the desired outputs that minimize the mean-square value of the actual error [15].
Both the Hebbian and the ADALINE neural networks are single layer feed-forward
neural networks.
The genetic algorithms are used to develop neural networks in an evolutionary
process. The process is based on natural selection, crossover, and mutation [42].
Typically the input parameters are treated as a chromosome, and a number of chro-
mosomes based on the input parameters are randomly created. Then, each chro-
mosome is tested for relative “fitness” using a fitness function. The fitness function
evaluates the performance of the chromosomes ability to solve the problem and selects
the best chromosomes to breed and create the next generation of chromosomes [43].
The evolutionary process continues until a satisfactory solution is obtained. A num-
ber of genetic algorithms are available for this process, but the typical process is
demonstrated in the following algorithm:
• Encode the decision variables as a chromosome.
• Initialize a set of chromosomes as the first generation.
• Repeat until the stopping criteria is met:
• Evaluate the objective function values for the current population.
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Figure 4.13: The ADALINE neural network. p refers to the matrix
of input vectors. R refers to the number of inputs to the
input layer. W is the weight matrix. b represents the
bias vector. S is the number of neurons in the output
layer. The plot in the lower right corner of the figure
illustrates the linear training function. In the small
graph to the right, the x-axis represents the input, p
and the y-axis represents the output, a.
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Figure 4.14: The backpropagation neural network. R refers to the
number of inputs to the input layer. S refers to the
number of neurons in the output layer. P is the matrix
of input vectors(R × the number of training pairs). W
is the weight matrix and b refers to the bias vector.
n is the matrix of values output from he first layer of
neurons. f refers to the transfer function. a indicates
the matrix of output vectors.
• Select some chromosomes with higher fitness values to produce children for the
next generation.
• Apply crossover and mutation to the parent chromosomes selected in the pre-
vious step.
• Replace the entire population with the next generation. [15]
The backpropagation algorithm is used to efficiently calculate the derivatives of
some output quantity of a nonlinear system with respect to all inputs and parameters
of that system through calculations proceeding backwards from outputs to inputs
(Figure 4.14 and Figure 4.15) [44]. When backpropagation is applied to neural net-
works the inputs are propagated forward through the neural network. Then, the
sensitivities are propagated backwards through the neural network and finally the
weights and biases are updated using the approximate steepest descent rule [45]. The
hidden layer uses a non-linear transfer function, commonly a log-sigmoid.
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Figure 4.15: The backpropagation neural network and transfer func-
tions. The row of plots on the left hand side of the dia-
gram illustrate the possible transfer functions that can
be used with a backpropagation neural network. For
these plots, the x-axis refers to the input, p, and the
y-axis represents the output, a. Refer to Figure 4.13
for the definition of variables seen in the figure.
38
Chapter 5
Methodology
The original impedance spectrometer was developed for animal model experiments in
a controlled laboratory environment. In that setting it performed well, however, per-
formance with human subjects in a clinical environment is different and required the
implementation of a number of features and protocols. The overall goal of the project
is to develop a non-invasive ischemia monitoring device. Thus, a major step in this
research is to develop a methodology for non-invasively measuring tissue impedance.
Invasive pH measurements will be used as a temporary control until a quantitative
relationship between impedance and pH is established. Once such a relationship is
established the invasive pH measurements will no longer be necessary. A number
of steps were necessary in order to prepare the impedance spectrometer for clinical
studies as well as to conduct them. These steps included gaining electrical safety
approval, selecting appropriate electrodes, and developing sterilization, calibration,
and operating room procedures. This chapter presents the methodology of system
development necessary in order to achieve a clinically usable measurement system.
5.1 Electrical Safety Approval
Before any medical instrument can be used in a clinical environment, it must be
tested for compliance with the electrical safety regulations put forth by the National
Fire Protection Agency and the Association for the Advancement of Medical Instru-
mentation (AAMI). The codes/regulations that the instrument must meet before it
can be used in the hospital environment relate to:
1. Patient Grounding
2. Cord Connected Apparatus
3. Isolated Patient Connections
In order to use the ischemia monitoring instrument in clinical trials it had to
be tested by the clinical engineers at the UMass Memorial Medical Center where
it was employed. The portion of the instrument designed by George Gumbrell [9]
that directly monitors tissue pH had received prior approval provided the use of an
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external medical grade isolation transformer. The impedance spectrometer had never
been used in a clinical situation and thus had not received prior approval. As with
the pH monitoring unit used by George Gumbrell, the impedance spectrometer was
also given approval provided it was used in conjunction with an external medical
grade isolation transformer. The use of the external medical grade transformer was
necessary to prevent excessive leakage currents.
5.2 Selection of Electrodes
Electrodes ideal for use with the impedance spectrometer and pH monitor during
clinical studies had to be determined. For the impedance spectrometer we relied
on the results of our previous studies [10] suggesting that the optimal electrode for
use in clinical impedance spectroscopy is the MedicoTest Blue Sensor Q-00-A ECG
electrode. The Blue Sensor Q-00-A ECG electrode is a disposable wet gel ECG
electrode. It was chosen for use in clinical studies because it had the largest usable
bandwidth (defined as a region with recorded noise of less than 5% of the signal) and
the lowest average percent noise from 1kHz to 100kHz of the 10 electrodes tested in
previous studies [10]. The only drawback to the Blue Sensor Q-00-A electrode is that
it is not sterile out of the package. For the pH monitor, the electrode choice and
sterilization procedures were slightly more complicated.
Initially, the MI-414 Micro-Combination pH 16 gauge Needle Electrode manufac-
tured by Microelectrodes, Inc. were going to be used during the study. This decision
was based on the fact that the MI-414 electrodes had been used in a previous study
to monitor tissue pH in wounds and that a separate reference electrode was not nec-
essary [35]. Unfortunately, as it became time to prepare for the surgical procedure
and sterilize the electrodes, we realized that the MI-414 would be inappropriate for
our study. This was due to the fact that the electrode needs to be filled with a KCl
solution after sterilization. During the previous studies this was acceptable because
the electrodes only contacted the surface of the wound, but in our study the electrode
is embedded in the tissue, thus absolute sterility is required. Since the combination
electrode had the potential for leakage, it was unacceptable for this study. The MI-508
Flexible pH Electrode manufactured by Microelectrodes, Inc was selected for actual
use in the study. This electrode was successfully used in the original clinical studies
of the pH monitor [9]. They could be easily sterilized and did not require the addi-
tion of KCl post sterilization. The only disadvantage to these electrodes was that a
separate reference electrode was necessary. An additional ECG electrode placed on
the patient was able to act as a reference and solved this problem.
5.3 Sterilization
In the operating room (OR) it is important that everything that comes in contact
with the patient is sterile in order to reduce the occurrence of complications due
to possible infection. For our study, this means that all of the electrodes and the
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cables used to connect the electrodes to the instrument have to be sterilized. When
evaluating possible procedures for sterilization, we had to take into consideration
the temperature sensitive nature of pH electrodes and the moisture sensitive nature
of the electronic components included in the cable for the impedance spectrometer.
UMass Memorial Medical Center (UMMC) offers three basic methods for sterilization:
autoclaving, ethylene oxide sterilization, and Sterrad sterilization.
Autoclaving is a high temperature sterilization technique that uses steam and
pressure. It is a 20 minute procedure carried out at 15psi of pressure and 121.5oC [46].
Due to the high temperature and the moisture, this process would be inappropriate
for both the pH electrodes and the cables.
Ethylene oxide sterilization is a fairly low temperature process (55oC) that uses
heated gas to kill bacteria and other contaminants. This process was employed in
the work done by both George Gumbrell and Susan Shorrock [35,9]. Despite the low
temperature and low humidity there are a number of disadvantages to using ethylene
oxide sterilization for this research. The first is that UMMC only does ethylene oxide
sterilization twice a week, on Sundays and Wednesdays. This decreases our access
to the sterilization process and would necessitate a larger pool of electrodes so that
studies could be performed on consecutive days. Inherent drawbacks of the procedure
are that ethylene oxide is a known carcinogen and thus, a lengthy aeration period (12
to 16 hours) is necessary to allow the total dissipation of ethylene oxide residue [47].
Additionally, prior research indicates that the 55oC gas sterilization procedure alters
the characteristics of the electrodes due to the elevated temperature [9].
Sterrad sterilization utilizes low-temperature hydrogen peroxide (H2O2) gas plasma
to sterilize devices without heat, moisture or toxic residues [48]. In this process the
hydrogen peroxide is vaporized using radio frequency energy which creates an electro-
magnetic field. The hydrogen peroxide is converted into free radicals which destroy
microorganisms. When the energy is removed from the system the free radicals form
non-toxic by-products (oxygen and water). This process is carried out at 50oC and
takes approximately one and a half hours. This process has a number of advantages
for our application. First, it is a low temperature, low moisture procedure, so it is
appropriate for both the pH electrodes and the cables. It is done multiple times a day,
and seven days a week at UMMC, making it more convenient than the ethylene oxide
procedure. Lastly, the temperature is slightly lower than that required for ethylene
oxide, which will reduce the temperature related alterations of the pH electrode char-
acteristics. Sterrad sterilization was determined to be the best sterilization technique
for both the pH electrodes and the impedance spectrometer cables.
Unfortunately Sterrad sterilization and all of the other sterilization methods eval-
uated would be inappropriate for use with the Q-00-A ECG electrodes due to the
sensitive nature of the electrodes and the electrode gel. The solution to this problem
is to keep the electrodes out of the sterile field and isolate them using steri-drapes.
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5.4 Calibration and Data Collection
Both the pH monitor and the impedance spectrometer have to be calibrated prior
to each use. For the pH monitor both a two point and a one point calibration are
necessary. The initial calibration procedure is carried out prior to arrival in the
operating room. This includes an initial calibration procedure for the impedance
spectrometer that does not need to be repeated prior to each case and a two point
calibration procedure for the pH monitor that does need to be carried out prior to
each case.
5.4.1 Impedance Spectrometer Calibration
Calibration of the impedance spectrometer is necessary to minimize the effects of
stray capacitances on the system and reduce the effect of the cable with the built-in
preamplifier on the measurement results of the system (See Section 4.5.2). Initial
calibration is done with a 50Ω resistor so that the gain of the electronics can be
assessed. The instrument then needs to be calibrated with the electrodes and cable
that are used for clinical trials. This is accomplished by attaching the electrodes to
a tank filled with a saline solution with an impedance of approximately 50Ω. A salt
bridge interface is used between the electrodes and the saline in order to maintain
the integrity of the electrode gel [10].
The impedance calibration is done once for each cable, and since the same cable
and electrodes are used in each case, the entire procedure does not need to be repeated
before every case. A calibration file is created for each of the cables used in the study
at each of the programmable voltage gains (1, 3, and 10). After the calibration files
are created, the appropriate calibration file needs to be loaded prior to each use of
the instrument. The initial calibration procedure is explained later in this section.
The program used for impedance calibration and data collection is the main program
developed using LabWindows/CVI Software and named is124 (See Appendix A). A
brief description of the user interface for the is124 software is provided before the
detailed calibration procedure is presented.
The main window for the is124 program is illustrated in Figure 5.1. Across the
top of the window is the title, including the name of the file to which the data will
be stored, in this case isdata1.imp. Below the title bar is the menu bar. The File
menu contains options to open, save, and exit the file. The system setup menu option
allows you to change parameters for the pH and impedance monitoring setups. The
Imp-Calibration allows you to load, save, or create a new impedance calibration file.
The pH-Calibration button presents the user with the option to perform either a one
or two-point pH calibration. The Info Input option allows you to add notes to the
data file. The View menu option allows the impedance to be viewed as a function of
frequency or time and allows the pH to be viewed as a function of time. The box in
the upper left hand corner of the window shows the current time. Then, proceeding
to the right, the next box is labelled Graph and allows the value plotted in the main
window to be changed. The options include views of current, voltage, magnitude,
and phase. The next block, labelled Signal Freq, offers the selection of the frequency
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at which the voltage and current plots are displayed. The next button, labelled
ESU Block, permits the electro-surgical unit filter to be turned on or off. The final
block, labelled Error, displays any errors. The box in the center of the screen shows
the plot selected with the graph and Signal Freq options above. The remaining boxes
proceeding from top to bottom along the left side of the window are V-gain, which sets
the voltage gain to 1, 3, or 10. C-gain, which sets the current gain to 1, 3, or 10. The
injected current is always 100µA. The variable gain is to achieve the best resolution
of the measured current through the A-D converter. The Delay option sets the delay
between measurements. The CONT ACQ button starts a continuous acquisition.
The ACQUIRE button performs a single data acquisition. The INITIALIZE button
initializes and resets the system and should be clicked prior to each calibration. The
small box in the lower left hand corner illustrates the frequency at which data is
currently being collected. In the lower central portion of the window a number of
values are displayed including: Voltage, Magnitude, Phase, Noise, R0, Rinf , Alpha,
and Tau. On the lower right hand side of the window, below the plot, are the filtering
options. The top option, labelled Nyquist Freq, selects special frequencies set to be
equidistantly spaced throughout the Nyquist plot. The Smoothing button selects
the smoothing filter. The DC Offset button activates the systems automatic DC
offset elimination procedure. The C DC box shows the compensated DC offset of
the current and the V DC box shows the compensated DC offset of the voltage. The
description of the user interface provides a familiarity with the basic interface that is
useful in understanding how the calibration procedure is carried out.
Calibration Procedure:
1. Attach the desired cable to the impedance spectrometer.
2. Attach a 50Ω resistor to the instrument.
3. Check to ensure that the DC offset elimination is activated
4. Select the Imp-Calibration item from the menu (Figure 5.2), then choose New.
When prompted, calibrate the instrument with a 50Ω resistance and 0 phase.
5. Click on the Acquire button on the main screen (Figure 5.1) to acquire a single
set of data.
6. Check the display to ensure that the calibration was successful(resistance and
phase data should be flat). Voltage and current should be evenly distributed
±1200 − ±1500. If not, adjust the voltage and current gains to be within the
optimal range. If there is a significant offset, conduct a few more acquisitions,
which will enable the automatic offset elimination algorithm to adjust for the
error.
7. Prepare the salt bridges for the saline tank, then fill the saline tank with a 50Ω
saline solution [10].
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Figure 5.1: Main is124 program window. The window is explained
in detail in Section 5.4.1.
Figure 5.2: Calibration menu item. From this menu a calibration
file can be created by clicking on new, saved, or loaded.
Additionally, the Single Freq option allows the system to
be calibrated at a single frequency selected by the user.
44
8. Attach electrodes to saline tank and cable.
9. Perform a single acquisition.
10. Repeat Step 6.
11. Calibrate the instrument using the resistance of the saline tank from the single
acquisition at 1kHz and with zero phase.
12. Perform a single acquisition to ensure proper calibration. The resistance and
phase should be reasonably flat and neither the current nor the voltage mea-
surements should saturate at any frequency.
13. Select the Imp-Calibration option from the menu (Figure 5.2) and Save the
calibration file.
The saved file can then be used during the clinical studies. Calibration with
the saline tank is necessary so that the instrument can be calibrated using the same
electrodes that will be used during surgery in a clinical situation. Once the calibration
file is saved, it can be used for all following cases as long as the same cable, voltage
gain, and electrode style and brand are used. So, for each cable, gain setup, and
electrode type, a separate calibration file has to be developed.
5.4.2 pH Calibration
Two separate calibrations are necessary for the pH monitor due to the fact that
sterilization slightly alters the characteristics of the pH electrodes. First, a two-point
calibration is conducted, then later, in the OR, an additional one point calibration is
performed. The two point calibration is explained below. The calibration is conducted
using the suepH program, which was originally developed in LabWindows/CVI by
Susan Shorrock [35].
1. Place a MI-508 pH electrode in a pH 4.0 buffer solution for 12 hours in order
to pre-condition the electrode.
2. Then, place the electrode in a sterile lactated Ringers solution for 1 hour prior
to calibration to condition the pH electrode (pH 5.0).
3. Place stock buffers of pH 6.0 and pH 8.0 into test tubes.
4. Attach the pH electrode and the reference electrode to the instrument.
5. Run the suepH program.
6. Select pH-Calibration from the main menu bar, then select the Two-Point Cal-
ibration option as illustrated in Figure 5.3.
7. Place the pH and reference electrodes into the pH 6.0 buffer solution.
45
Figure 5.3: The suepH program calibration menu. Before each use
the pH electrodes are calibrated using the Two Point
Calibration from the menu. For details refer to Sec-
tion 5.4.2.
Figure 5.4: The stabilization prompts from the suepH program.
While calibrating the pH electrodes ensure that the volt-
age is stable before continuing to the next buffer solution.
For details refer to Section 5.4.2.
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8. Follow software prompts to enter actual pH values and allow for electrode sta-
bilization (Figure 5.4).
9. At prompt, place the pH and reference electrode into solution 2, pH 8.0.
10. Follow software prompts to enter the actual pH values and wait for stabilization.
11. Record the slope and intercept values calculated by the program.
The slope and intercept values are recorded for each pH electrode. Then the pH
electrodes are sterilized using Sterrad at UMMC (See Section 5.3). The electrode is
not removed from the sterile packaging until the scrub nurse in the operating room
is able to place it in the sterile field.
5.4.3 In the Operating Room
A number of steps need to be taken to prepare the instrument in the OR and collect
data. The following is the ideal operating room procedure.
1. Arrive at the OR one hour prior to the scheduled surgery.
2. Visit the patient, explain the procedure, the purpose of the research, and present
the consent form to patient in order to acquire appropriate signatures (See
Appendix C).
3. Give the scrub nurse the sterile pH electrode in order to soak it in sterile Lac-
tated Ringers solution for 1 hour (must be done in the sterile field).
4. Launch the is124 program by double clicking on the IS icon.
5. Click on the Imp-Calibration menu option, then click on the Load file option
(Figure 5.2). Load the appropriate calibration file created according to the
procedure listed in Section 5.4.1. The calibration files used for this project
are listed in a window which is displayed in Figure 5.5. The files were coded
such that the file 50 cl g3.clb would refer to the calibration file for the 50Ω
resistor with cable 1 and a gain of 3. The sa heading would refer to saline tank
calibration and c1 and c2 refer to cable 1 and cable 2 respectively. The g1, g3
and g10 files refer to the three different programmable gains. For the clinical
studies g3 was primarily used. For calibration purposes in the operating room,
only the calibration files with a sa prefix are used.
6. Do a single acquisition of data from a 50Ω resistor to ensure proper functioning
of the impedance spectrometer.
7. Place the pH reference ECG electrode on the patient at an uninjured site above
the tourniquet (Figure 5.6).
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Figure 5.5: The calibration files window from the is124 program.
For clinical trials only the files with a sa prefix were used
in the operating room. For more details please refer to
Section 5.4.3.
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Figure 5.6: Placement of the tourniquet and pH reference electrode
on the patient in the OR. Note the placement of the pH
reference electrode above the tourniquet.
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Figure 5.7: Placement of impedance monitoring electrodes on pa-
tient in the OR. Please note that they are placed below
the tourniquet, but above the injury site. See Step 8.
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Figure 5.8: The System Setup menu option for the is124 program.
The pH Probe Setup is highlighted and is clicked in order
to enter the values obtained in the two-point calibration.
For details see Section 5.4.3.
8. Place the four ECG electrodes for impedance spectroscopy longitudinally along
the muscle below the tourniquet (Figure 5.7). Tape the cable in place to prevent
movement during the procedure and reduce motion artifacts.
9. Have the surgeon implant the pH electrode in the tissue of the patient using a 12
gauge 3.00IN 2.8×76mm Angiocath below the tourniquet site and in the fleshy
part of a muscle. Tape the electrode in place to minimize motion artifacts.
10. Wait 10 to 20 minutes for the electrodes to equilibrate.
11. Choose the System Setup menu option (Figure 5.8) and choose pH Probe Setup.
Enter the slope and intercept values (for the pH electrode that was implanted
in the patient) obtained during the prior two point calibration into the software
as appropriate (Figure 5.9), then click the Enter button followed by the Cancel
button.
12. Perform one point pH calibration:
(a) Obtain an arterial blood sample (Done by hospital staff).
(b) Perform blood gases and arterial blood pH measurement (Done by hospital
staff).
(c) Obtain results from nurse.
(d) Go to the pH-Calibration menu option and select the One Point Calibration
(Figure 5.10).
(e) Enter the blood pH value from the pH analysis
13. Double check impedance and pH setup. Then, do a single acquisition to ensure
appropriate voltage waveforms, current waveforms and pH values.
14. From the System Setup menu of the is124 program (Figure 5.8), click on
the Imp-Frequency Select option and select desired frequencies (typically all
of the available frequencies between 25Hz and 1MHz), then save the file as
Patient*.imp.
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Figure 5.9: The pH Probe Setup window for theis124 program. The
slope and intercept from the prior two-point calibration
are entered in the appropriate areas. For details see Sec-
tion 5.4.3.
Figure 5.10: The One Point Calibration menu option for pH from
the is124 program. The Two Point Calibration is al-
ways done using the suepH program instead of the is124
program.
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15. Begin continuous measurements by clicking on the CONT ACQ button (Fig-
ure 5.1).
The procedure outlined above is the ideal operating room (OR) procedure. Un-
fortunately, a number of modifications have been made to this procedure in order to
account for the dynamic atmosphere in the OR. A list of procedural changes follows
to Steps 3, 8, 10, and 12 follows.
• Step 3: The pH electrode typically only soaks for 30 minutes, but any time
beyond 15 minutes is considered adequate. The reason for this modification is
that the time between when the sterile field is established and the pH electrode
needs to be implanted is frequently less than an hour, thus it is impossible to
soak the electrode within the sterile field for more than an hour.
• Step 8: The area between the tourniquet and the injury site is frequently
quite small. Thus perfect placement of the electrodes is not always possible.
Electrodes are typically placed as close to each other as possible. If there is
not enough space for a completely longitudinal placement, then the electrodes
through which the current is injected are placed slightly out of line. Also, if there
is not enough room longitudinally along the muscle it is sometimes necessary
to place one of the current injecting electrodes over less muscular tissue. The
recording electrodes are always placed longitudinally over muscular tissue. Also
the cable needs to be taped appropriately in order to ensure that the electrodes
do not detach from the patient.
• Step 10: The tourniquet times (ischemic events) typically last for approximately
one hour and begin almost as soon as the patient is anesthetized. Thus, in or-
der to maximize the amount of data collected we dynamically determine the
amount of time the electrodes are allowed to equilibrate. This procedure con-
sists of acquiring data immediately after electrode placement in order to see
if the electrodes are equilibrated and continued single acquisitions of pH and
impedance data until the voltage and current values are within range (not sat-
urating) and the pH, magnitude, and phase data values have stabilized. After
everything has stabilized, continuous acquisition begins.
• Step 12: During the surgeries that we are attending, an arterial blood sample is
usually unavailable. In order to perform a one-point calibration, we assume that
the tissue has a pH value within the normal range (7.35-7.40) and is approxi-
mately 7.4. The instrument is then calibrated using the one-point calibration
option and an assumed pH value of 7.4.
After continuous measurements have started, be sure to note key events during
the surgery such as the time at which the tourniquet is inflated/deflated and the
occurrence of any problems. Also, if the surgeons are using the electrocautery device
be sure to click on the ESU Block button (Figure 5.1) in order to prevent interference
of the electrocautery device from affecting the data. See Chapter 6 for details on the
implementation of the ESU Block filter.
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Chapter 6
Clinical Design Improvements
Both of the original instruments, the impedance spectrometer and the pH meter, were
developed for in-vivo animal measurements. They were not designed for use during
surgical procedures on human subjects. One of the aims of this project was to identify
and perform necessary modifications to the system design to enable instrument use in
a clinical setting. During the course of clinical trials a number of software, hardware,
and methodology improvements were necessary. The modifications to the protocol are
explained in the Chapter 5: Methodology. Improvements to hardware and software
included modifications of existing modules, as well as the development of additional
modules. These modifications are explained in this chapter.
6.1 Software
A number of software improvements were made. These modifications included adjust-
ments to the data format, frequency selection, DC offset adjustment, gain selection
and data acquisition. The adjustments to the data format allowed for the output file
from the impedance spectrometer to more easily be input into Microsoft Excel r© for
data analysis. This modification was made to the is124 program. In order to easily
evaluate the quality of the data collected, a number of external software modules were
created (Perl Scripts) that facilitated additional data formatting and analysis (See
Appendix A). Within the is124 program, the frequency selection was modified to
increase the number of frequencies at which data was acquired. An adjustment to the
software was conducted in order to ensure that by default the instrument eliminated
the DC offset. After the clinical trials began, it was observed that the voltage gain
of the instrument was not the same as that indicated in the main program window.
This prompted rigorous testing of the system to determine what the gain actual was
and whether the software or hardware needed improvement. It was determined that
the software was in the greatest need of improvement because the default gain sent
to the D/A converter was incorrect. This value was corrected and tests showed that
the newly determined gain was appropriate. Finally, a major improvement was made
to the data collection algorithm. This change is explained in Section 6.1.1.
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6.1.1 Electro-Surgical Unit Block
During certain surgical procedures anomalies within the recorded impedance data
were observed. These problems manifested themselves as a temporary saturation of
the recorded voltage even though the injected current remained unchanged. Errors
in the recorded pH values were also observed. We were able to determine that the
cause of the voltage saturation was the electro-surgical unit (ESU) employed by the
surgeons to cut or coagulate. Whenever the ESU was in use, the recorded voltage
saturated. The ESU, when used for cutting/coagulating, operates in a frequency
range from 500kHz to 2.5MHz. The open-circuit voltages are as high as 9kV with
power levels ranging from 100 to 750 Watts [32], and an injected current on the order
of amperes. Our instrument applies a small current to the tissue, approximately
100µA. The magnitude of the ESU current is ten thousand times greater than that
which we are injecting, which causes the ESU current to saturate our input high gain
circuits, leading to inconsistent and erroneous readings of the voltage and impedance
of the tissue.
After the source of the impedance measurement error was determined, a num-
ber of possible solutions were evaluated. Possible hardware and software solutions
were considered. One possible solution would be to implement either a hardware
or software filter to filter out data with a frequency above 500kHz. Unfortunately,
we are collecting data with frequencies up to 1MHz and it is not possible to recover
information form the signal once it is saturated. Thus, this solution would be less
than ideal. We could limit our frequency bandwidth to something under 500kHz and
employ filtering, but this would reduce the accuracy of our impedance measurements.
Additional software modifications were considered that would allow us to eliminate
the unwanted data from the ESU, but allow us to collect a full set of impedance data
across the desired frequency range.
The surgeons do not use the ESU continuously. They turn it on briefly to cut
or coagulate, then pause to do other things, before using it again. Thus, even when
the ESU is used throughout the period of time the tourniquet is inflated, it is not
in continuous use. By simply acquiring data while the ESU is idle and pausing the
acquisition while the ESU is active, full sets of impedance data could be acquired
with a minimal increase in the measurement acquisition time.
In order to do this, a new software module was created and added to the existing
program. The module utilizes a loop which evaluates the current or voltage value to
determine if the inputs to the impedance spectrometer are saturated. If the inputs
are saturated, then the software loops until the current and voltage values are no
longer saturated. The system performs this check and loops (as necessary) for each
frequency. Due to the short duration of the ESU use, the overall measurement time
is increased by a maximum of 30 seconds when the ESU is in heavy use. After an
impedance spectrum is collected, the pH is acquired. The system enlists the same
style loop in order to ensure that the pH voltage is not saturated before the final
acquisition.
After the new software module was created, a button was added to the main
window called ESU Block. This option can be activated if the surgeons are planning
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Figure 6.1: The impedance magnitude at 1kHz recorded during a
surgical procedure in which the ESU was used before
the implementation of the ESU Block feature.
to use the ESU. After the software modifications were complete, the system with the
ESU block was tested. The instrument was then used during a surgical procedure in
which the ESU was being used. During the surgery we were able to observe a large
difference between when the ESU Block was employed and previous cases when it
was not available. Figure 6.1 shows impedance data acquired without the ESU Block
while the ESU was being used sporadically. Figure 6.2 shows impedance data acquired
when the ESU Block was employed while the ESU was being used sporadically.
6.2 Hardware
A number of small modifications to the system hardware were also necessary. After
collecting data from the operating room for the first patient, a number of difficulties
with the cable connecting the electrodes to the impedance spectrometer were observed
and resolved.
A number of problems with the instrument itself were also observed during testing.
These problems included random current and voltage saturations while the instrument
was being tested with a 50Ω resistor. In order to rectify this problem we added a heat
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Figure 6.2: The impedance magnitude at 1kHz recorded during a
surgical procedure in which the ESU was used as well as
the ESU block software feature.
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Figure 6.3: The ischemia monitoring instrument in the OR. Note
the distance between instrument and surgical site which
necessitated the use of long cables.
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sink to the frequency generator chip (DDS) to ensure that it was not overheating,
and added spacers between the board and the instrument case. Additionally, it was
determined that some of the chips and resistors were loose and needed to be soldered
into their sockets. Based on the spacing problems and the necessity to re-seat the chips
to ensure proper operation it was determined that a new, professionally created digital
board was desirable. The new board will be incorporated into the next generation
instrument.
6.3 Electrodes
The ECG electrodes we intended to use for impedance measurements were not sterile.
Two different techniques were used to solve this problem, depending upon the surgery
being conducted. One method was to apply the electrodes outside of the sterile field,
before the field was prepared. Unfortunately, application of the electrodes outside of
the sterile field was not always possible. In these cases the electrodes were applied
after the sterile field was established and steri-drape was used to isolate them from
the rest of the field, and a sterile cable was used that led from the electrodes, through
the field, and to the instrument.
Improvements to the method in which the pH probes were used was also necessary.
In the first cases the pH probe was implanted in the surgical site during the operation
so that an additional wound would not be inflicted upon the patient. This placement
was not ideal because the electrode was frequently within the surgeons work area
necessitating adjustments and leading to motion artifacts. The pH values were also
distorted when the site was flushed with saline. In order to reduce the affect of
motion artifacts and other problems, the surgeon began placing the probe outside
of the surgical field but the method with which they were implanted caused a large
number of the electrodes to break (the wires connected to the glass tip are very
fragile). In order to properly place the electrode is was decided that an angiocath
was necessary, but those in stock at the hospital were too small. A case of twelve
gauge angiocaths were ordered to improve electrode performance.
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Chapter 7
Direct pH Measurement Results
For this research two major types of data were collected. The first data type was the
tissue pH recorded from a glass microelectrode by a custom built pH meter (Chapter
7). The second data type was the tissue impedance spectra recorded from non-invasive
electrodes by a custom built impedance spectrometer (Chapter 8). Using the actual
pH and impedance data collected in the operating room, artificial neural networks
were utilized to estimate the tissue pH given parameters of impedance spectra as
input (Chapter 9). This chapter will focus on the results of the pH data collection.
7.1 Laboratory Results
Tissue pH was monitored during ischemic events because it was considered, for our
purposes, to be a golden standard for measuring ischemia. It has been established
that tissue pH changes as a result of ischemia, that such changes can be measured
using a pH probe, and measured values can be used for ischemia level estimation.
Due to the importance of the pH measurements in this research, it was necessary
to test the pH electrode performance in the lab. Thorough tests of the pH electrode
response to sterilization were performed by George Gumbrell [9] and the electrode
response to temperature was evaluated by Susan Shorrock [35]. Both investigators
determined that sterilization did not compromise system performance in clinical sit-
uations. Therefore, it was only necessary for us to perform laboratory tests that
verified the stability of electrode pH measurements, as well pH meter functional and
proper electrode use.
The pH data that we collected in the laboratory showed that the MicroElectode
MI-508 pH probe provided a stable, reliable measure of a given solution’s pH. Motion
artifacts were minimal, there was no electrical interference and the exact pH of the
solution was known. The results from a laboratory test of the pH measurement
stability are illustrated in Figure 7.1. During long term stability tests, pH data was
collected and the average drift slope of the 213 data points was calculated as 0.00003
pH units per minute, with the standard deviation is 0.003793. If the first seventeen
data points (Figure 7.2) are evaluated, the average slope of the line is -0.0003, the R2
value is 0.9874 and the standard deviation is 0.00178. The R2 value is the correlation
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Figure 7.1: The long term stability of the recorded pH in the labo-
ratory environment. The 213 values were collected over
a period of 320 minutes. The dashed line represents the
slope of the average drift.
coefficient and is mathematically defined in Equation 9.1.
7.2 Operating Room Results
Data was collected in the operating room from a total of sixteen different patients
(See Appendix A). The raw recordings normalized to a starting value of pH = 7.4 are
illustrated in Figure 7.3. The slope and the R2 values for the raw recordings of the
first 17 values from each case including the laboratory test are presented in Table 7.1.
Table 7.1 illustrates the wide variability in the average slope of the pH values for
each patient as well as the R2 values. Due to the use of the ESU, data recorded from
patients 2-7 are contaminated with ESU interference and therefore the measurements
are not representative of the actual data. Figure 7.4 contains only those recordings
that are not contaminated by ESU use. Even in cases where the electrosurgical
unit was not employed (Patient 1) or cases after the implementation of the ESU
Block feature which blocked the affects of the ESU (Patients 8-15), there is still large
variability in recorded slopes and R2 values and the recordings are quite noisy. An
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Figure 7.2: The first 17 pH data points recorded during the labora-
tory stability test. The time period is approximately 26
minutes.
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Experiment# Slope (pH/min.) R2
Lab -0.0002 0.9874
Patient 1 -0.0005 0.4092
Patient 2 +0.0018 0.0146
Patient 3 +0.0018 0.1857
Patient 4 -0.0023 0.4321
Patient 5 -0.0007 0.0113
Patient 6 -0.0137 0.9791
Patient 7 +0.7300 0.3379
Patient 8 +0.0003 0.0313
Patient 9 +0.0028 0.3524
Patient 10 +0.0047 0.7877
Patient 11 -0.0010 0.0048
Patient 12 -0.0010 0.0771
Patient 13 -0.0348 0.5551
Patient 14 -0.0058 0.6275
Patient 15 -0.0087 0.6030
Patient 16 +0.0036 0.585
Table 7.1: Slope (pH units per minute) and R2 for the pH data col-
lected from each patient. The first 17 data points for
each patient were evaluated in order to allow consistency
between patient data sets. Bold values are contaminated
by ESU use and may not represent the actual change in
pH of the tissue.
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obvious cause for variation in values and the noise is patient/electrode movement.
Surgeries are very dynamic, so frequently the patient’s limbs are moved/readjusted
and the surgeons must work around the electrode, often adjusting the position of the
wires to suit their needs. These movements induce motion artifacts. These artifacts
do not saturate the signal, but produce signal variations that fall within the range of
ordinary physiological changes in pH-therefore they can not be filtered out. This is
one of the major reasons that the pH signal is so inconsistent and noisy. Due to this
problem, regions of the signal that are noise and artifact free were manually selected
for further analysis.
Due to the wide variability and poor quality of the raw pH results, only select,
representative portions of the curve were used to characterize the data. The literature
states that the pH of the tissue decreases as it becomes increasingly ischemic. Previous
research also indicates that this decrease is somewhat linear in nature [5]. In order
to determine a general pH response to ischemia, the pH data was evaluated and the
largest range of continuous descent of the pH values was used to predict how the pH
value changed throughout the ischemic event. Table 7.2 lists the slope and R2 values
for the raw data, as well as the slope of the reconstructed curve based on the longest
region of continuous descent.
By determining the region of longest continuous descent and calculating the curve
based on that region, we are able to salvage data from the cases in which the elec-
trosurgical unit was used before corrective measures were implemented. We are also
able to obtain curves from data that is heavily contaminated with other sources of
noise and artifact.
Utilizing the raw data, the average calculated slope ranged from -0.0348 to +0.0583
with R2 values ranging from 0.0029 to 0.7726. By evaluating only select portions of
the curve, the range of the slope was dramatically reduced -0.0012 to -0.0153 and the
R2 values range from 0.4501 to 0.9939. The average slopes of the selected regions for
each patient are displayed presented in a bar graph in Figure 7.5. The average slope of
the raw pH data (after throwing out the highest and lowest value is: -0.0026 and the
average slope of the estimated select pH values is: -0.0052. The units corresponding
to these slopes are pH units per minute. After the slopes were determined, estimated
pH curves based on the calculated slopes for each of the sixteen cases were created.
These curves are illustrated in Figure 7.6.
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Pat. # Raw Slope Raw R2 Total# New Slope New R2 # based on
1 -0.00005 0.0382 32 -0.0014 0.5144 7 - 15
2 -0.0013 0.0126 42 -0.0034 0.8167 1 - 4
3 -0.0001 0.0029 60 -0.0034 0.5968 25 - 53
4 -0.0020 0.6122 33 -0.0049 0.8799 18 - 33
5 -0.0007 0.0113 17 -0.0153 0.6989 1 - 7
6 +0.0014 0.0933 88 -0.0012 0.7610 48 - 88
7 +0.0583 0.0371 45 -0.0139 0.4501 31 - 38
8 -0.0022 0.0100 56 -0.0055 0.9939 23 - 30
9 +0.0053 0.0936 20 -0.0072 0.7957 4 - 9
10 +0.0038 0.7726 21 -0.0023 0.6212 13 - 17
11 -0.0010 0.0048 15 -0.0033 0.4970 11 -15
12 -0.0011 0.1291 20 -0.0041 0.8745 10 - 17
13 -0.0223 0.4183 21 -0.0079 0.8282 17 - 21
14 -0.0076 0.7708 55 -0.0081 0.9046 3 - 10
15 -0.0075 0.5878 19 -0.0089 0.9462 9 - 17
16 +0.0007 0.1214 31 -0.0047 0.9511 1 - 7
Mean -0.0026 0.2601 36(575) -0.0052 0.7529 11(168)
St. Dev +0.0164 +0.0041
Table 7.2: The slope and R2 values for the entire data set of raw pH
recordings are presented along with the number of points
that comprised the raw data. Additionally, the slope and
R2 values from the region of longest continuous descent
are included. Note that the data for patient 2-7 is con-
taminated from ESU use and illustrated in bold. The
crossed out values were omitted from the calculation of
mean and standard deviation because they were associ-
ated with the highest or lowest slope value.
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Figure 7.3: The raw pH curves, measured directly and normalized
to a starting value of 7.4, for patients 2-7 are plotted
in the figure. This data is contaminated with ESU use,
with pH values ranging from 6 to 8.5.
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Figure 7.5: The slopes of the selected data points for each patient.
The error bars represent the standard deviation.
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pH values constituting the longest continuous descent.
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Chapter 8
Impedance Results
The non-invasive impedance spectrometer was used to collect impedance spectra dur-
ing controlled ischemic events in sixteen patients. The raw data collected consists of
the magnitude and the phase of the impedance measured at 95 selected frequencies.
Twenty parameters were then extracted from the spectra using algorithms developed
by Ristic´ [5]. The twenty extracted parameters are listed in Table 9.1. So far, our
team has been the only group to report the establishment of a quantitative correlation
between parameters of impedance spectra and ischemia. Twenty parameters were ex-
tracted from the impedance spectra and artificial neural networks were employed to
establish a global quantitative correlation between tissue impedance parameters and
pH. The establishment of the correlation between impedance parameters and pH is
explained in Chapter 9.
In this chapter we will not present the recorded behavior of all of the parameters
during ischemia, information regarding their behavior is available on the CD associ-
ated with this work (See Appendix A). The information presented in this chapter
and discussed later will focus on three of the impedance parameters recorded: R0,
IMMAX and FIMMAX. These parameters will be discussed due to the availability of
information regarding their response to ischemia.
8.1 R0 Results
R0 is the instantaneous resistivity at zero frequency. R0 was chosen for basic evalua-
tion of the quality of impedance recordings because its behavior during ischemia has
been both theoretically explained and experimentally verified. The absolute value of
R0 depends upon numerous physiological factors (distance between electrodes, muscle
type, and many others), however, regardless of the starting R0 value, as the tissue
becomes more ischemic, the value of R0 steadily increases. This increase is due to
the shift of fluid volume within the tissue from extracellular to intracellular. The low
frequency R0 value is particularly sensitive to the fluid volume changes because the
capacitances of the cell membranes at low frequencies act essentially as open circuits
for the measurement current causing increases in the resistivity of the tissue.
As with the pH data, the use of the electro-surgical unit (ESU) contaminated the
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Figure 8.1: R0 data contaminated with ESU interference. This fig-
ure presents the data from patients two through seven.
Note the spikes caused by ESU contamination.
recorded impedance data for patients two through seven. Figure 8.1 illustrates the
extent of contamination in the R0 data.
The impedance data recorded when the ESU was in use suffered from high levels
of contamination, however, when the ESU was not in use, or in the cases after the
implementation of the ESU block, the R0 data seemed to fall within normal physi-
ological ranges (Figure 8.2). Notice that the starting impedance is different in each
case and also that despite the elimination of ESU contamination, noise and artifacts
are still present in much of the data. The difference in starting point for the 16 pa-
tient’s data is due to physiological variations such as choice of muscle group, electrode
placement, and electrode separations.
As with the pH data, in order to determine the behavior of R0 as a result of
ischemia, data segments with minimal noise and artifact contamination were manu-
ally selected. The segments were selected to contain the largest region of data with
continuously increasing values. The slope, intercept, and R2 values were calculated
for each region and the resultant data is presented in Table 8.1.
Note that for patient two and patients four through seven values for slope etc.
are not calculated. This is due to the fact that within the entire data set three or
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The data from patient 9 was not included due to ir-
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Patient # Points R0 Slope R0 Intercept R
2
1 21(8-28) 0.0942 45.445 0.9565
2 0 – – –
3 5(39-43) 0.1053 53.454 0.8009
4 0 – – –
5 0 – – –
6 0 – – –
7 0 – – –
8 51(3-53) 0.0318 38.032 0.9315
9 4(5-8) 0.2639 51.546 0.9919
10 4(17-20) 0.0614 78.530 0.9958
11 4(2-5) 0.3185 42.031 0.9836
12 6(15-20) 0.1115 54.914 0.8992
13 7(1-7) 0.1489 31.824 0.9180
14 17(38-54) 0.0531 29.040 0.9877
15 4(5-8) 1.6236 59.566 0.9311
16 6(2-7) 0.1701 70.694 0.9285
Avg. 11(129) 0.1481 37.952 –
Table 8.1: R0 vs. time: slope, intercept, and R
2 values. The slope
is presented in Ω/minute. Patients from which 0 good
points were selected were subject to ESU contamination.
Italics are used to indicate the highest and lowest slope
values and their associated intercepts.
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more consecutive data points with increasing values do not exist. Those cases were
also contaminated most heavily with ESU use. The average slope of the R0 values
was 0.1481 Ω/minute after the largest and smallest slopes were removed. The data
points listed in Table 8.1 are those that will be used for neural network development.
8.2 IMMAX Results
IMMAX is the value of minimum reactance. IMMAX was chosen for evaluation
because it had been previously established that its value should decrease throughout
the course of ischemia [5]. This is likely due to the increased contribution of the
reactive element of the tissue as it becomes ischemic and the fluid volume shifts from
extracellular to intracellular.
IMMAX values were evaluated for each patient. Their values for patients 2
through 7 are contaminated with ESU interference and are illustrated in Figure 8.3.
The data for patients 1,8, and 10-16 are illustrated in Figure 8.4. The data for these
patients was not contaminated by ESU use, however, the data is still quite noisy.
Using the same points selected for R0 evaluation (chosen as the longest continu-
ously decreasing R0 values), IMMAX was also evaluated. The same points were used
because analysis of the overall impedance requires that not just R0 values be evalu-
ated, but the other parameters of impedance data collected at the same time be eval-
uated. Table 8.2 lists the slope, intercept, and R2 values for the selected impedance
regions. Note that for every curve, except for Patient 2 (one of the ESU contaminated
data sets), the slope is negative as expected based upon prior research [5], indicat-
ing a decrease in IMMAX as the tissue becomes increasingly ischemic. Despite the
solidarity in negative slopes, the R2 values range greatly and are, on average, much
lower than the R2 values for the R0 parameter from which the point selection was
based. The average slope of IMMAX after the highest and lowest values are rejected
is -0.0545 Ω/minute.
8.3 FIMMAX Results
FIMMAX is the frequency at which the reactance has its minimum. FIMMAX was
chosen for evaluation because it had been previously established that as the tissue
becomes more ischemic, the minimum reactance frequency decreases. The minimum
reactance frequency was also affected by the ESU and the contaminated data is il-
lustrated in Figure 8.5. In fact, FIMMAX seemed more sensitive to ESU use that
the other parameters we evaluated (R0 and IMMAX). The data that was not con-
taminated by ESU use is illustrated in Figure 8.6. This data does not exhibit the
large variations in data values that the ESU contaminated data exhibited, but is still
contaminated with noise and other artifacts.
In order to evaluate the data, the manually selected sections of data chosen for R0
and IMMAX evaluation were chosen. This permits us to observe the quality of the
three parameters R0, IMMAX, and FIMMAX extracted from the impedance spectra
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Figure 8.3: IMMAX (minimum reactance) data contaminated with
ESU interference. This figure presents the data from
patients two through seven. Note the spikes caused by
ESU contamination.
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Figure 8.4: The IMMAX (minimum reactance) values for patients
1,8, and 10-16 are presented. The data from patient 9
was not included due to irregularities in the data result-
ing from electrode-patient contact problems.
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Patient # Points IMMAX Slope IMMAX Intercept R2
1 21(8-28) -0.0326 -8.9014 0.9242
2 0 – – –
3 5(39-43) +0.1134 -2.2738 0.5012
4 0 – – –
5 0 – – –
6 0 – – –
7 0 – – –
8 51(3-53) -0.0114 -7.7753 0.6888
9 4(5-8) -0.1775 -6.3750 0.3835
10 4(17-20) -0.0204 -14.404 0.0204
11 4(2-5) -0.0861 -4.6110 0.9273
12 6(15-20) -0.0570 -7.3945 0.8459
13 7(1-7) -0.0499 -7.1465 0.0.6389
14 17(38-54) -0.0225 -6.0624 0.9283
15 4(5-8) -0.3198 -6.6018 0.8481
16 6(2-7) -0.0334 -5.629 0.3057
Avg. 11(129) -0.0545
Table 8.2: IMMAX (minimum reactance) vs. time: slope, intercept,
and R2 values. The slope is in terms of Ω/minute. The
data from patients 2 through 7 is heavily contaminated
with ESU use and in many cases resulted in zero usable
points.
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Patient # Points FIMMAX Slope FIMMAX Intercept R2
1 21(8-28) -109.78 34269 0.8216
2 0 – – –
3 5(39-43) N/A N/A N/A
4 0 – – –
5 0 – – –
6 0 – – –
7 0 – – –
8 51(3-53) -26.49 37020 0.202
9 4(5-8) -1240.50 39519 0.765
10 4(17-20) -407.72 38815 0.4986
11 4(2-5) -863.02 19719 0.9476
12 6(15-20) -270.65 47261 0.3773
13 7(1-7) 249.38 41032 0.3596
14 17(38-54) -147.17 41014 0.7140
15 4(5-8) -7356.9 94915 0.4418
16 6(2-7) -126.54 42213 0.0126
Avg. 11(129) -354.65
Table 8.3: The slope (Hz/minute), intercept, and R2 values for FIM-
MAX (the frequency of the minimum reactance) are listed
as is the average slope. See the explanation for the dis-
missal of data for patient 2 in the associated text (Sec-
tion 8.3).
at the same time points. The data collected from Patient 2 (an ESU contaminated
case) in the selected region exhibited no change and was listed in raw data file as
having an FIMMAX of 1MHz at every time point. This was due to ESU contami-
nation and for FIMMAX analysis, the Patient 2 data was disregarded. The slope,
intercept, and R2 values for FIMMAX in the remaining patients are listed in Ta-
ble 8.3. A large variability in the FIMMAX slopes is apparent, with slopes ranging
from -1240Hz/minute to -25.49Hz/min (after the high and low values are discarded).
This average slope being -354.65Hz/min. These values are all negative, which was
expected based upon prior work [5], indicating a decrease in FIMMAX as the tissue
becomes more ischemic.
Despite the selection of identical time points for use in R0, IMMAX, and FIM-
MAX evaluation, large discrepancies in the quality of data exists between the three
parameters. R0 data had the highest quality for the selected time points, and FIM-
MAX exhibited the worst quality. Using the R2 values as an indicator of data quality
and setting an arbitrary threshold of 0.70 as a reasonable quality, only the data from
patients 1, 11, and 14 would be considered to be of reasonable quality for all three
parameters.
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Chapter 9
Neural Networks
In order to develop a clinical impedance spectrometer for ischemia monitoring, the
measured values need to be converted to equivalent pH values. The relationship
between human muscular tissue pH and impedance parameters is highly nonlinear
and has not been previously established (See Section 4.6.2). Our hypothesis is that
a knowledge-based classifier will reproduce such a relationship automatically, after
appropriate training.
Three aspects of neural network design were explored during this research (Refer to
Section 4.7). The first was the evaluation of a number of different neural network types
and their performance classifying a small sample set of human impedance spectra
(magnitude and phase) and the pH value associated with the impedance data. This
will be described in Section 9.1. The second aspect of neural network design was
to evaluate the performance of the neural network used in a previous phase of the
research and improve upon it for future use, both in animal studies and studies
involving human tissue impedance. Data collected during the prior animal studies
is used in this phase of the research work. In the final phase of neural network
development the network designed and evaluated as described in Section 9.2 is trained
and tested with available clinical human ischemia data (impedance and pH data as
presented in Chapters 7 and 8).
9.1 Part 1: Network Selection
In order to determine the appropriate type of network to classify impedance data,
three different types of pattern classification neural networks (NNs) were evaluated:
the Hebbian, ADAptive LINear Element (ADALINE), and backpropagation(BP) neu-
ral networks. The data utilized for this phase of the research consisted of impedance
spectra obtained from a human forearm during a tourniquet surgery at the Univer-
sity of Massachusetts Medical Center. Thirty-eight measurements, each consisting of
impedance magnitude and phase at 95 frequencies (25Hz - 500kHz) as well as tissue
pH were collected. The raw data had an average inherent noise of 1.57%. The pH val-
ues corresponding to the impedance data were quantized as 4-bit quanta representing
pH values ranging from 7.1 to 7.4. They were then used to train the NNs.
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Each neural network was tested with the raw magnitude, normalized magnitude,
and raw phase data. The input to the networks consisted of the 95 points of either the
magnitude or phase data, and the output from the neural network was the pH value.
The normalized magnitude was calculated by determining the mean value of the
impedance spectra and subtracting that from the original signal. After the results
were obtained for the magnitude and phase data evaluated individually, the best
neural network for the magnitude data was combined with the best neural network
for the phase data and results for the combined magnitude and phase data were
evaluated. Sets of noisy (signals uniformly contaminated with white noise) and clean
data were tested. The noisy signals were created by generating an array of normally
distributed random numbers with the Matlab r© randn function, multiplying it by
a noise level from 0 to 1, and then adding a different random noise value to each of
the original data sets. All of the neural networks were then tested with noise levels
from 0 to 1, with 100 averages taken for each noise level to achieve a statistically
meaningful output. The recognition error was then defined as the average number of
incorrectly classified pH values at each noise level over the course of 100 averages. For
example, if all of the impedance spectra corresponded to the appropriate pH values
at a given noise level, the recognition error would be 0%. If all of the values were
classified incorrectly, the recognition error would be 100%.
Specific design parameters for the ADALINE and backpropagation (BP) neural
networks were established using Matlab r© Neural Networks (NN) Toolbox. The
ADALINE neural network was tested with a training goal of 1.e-6. Multiple permu-
tations of the BP neural networks were tested. The training goal for the BP neural
networks was also set as 1.e-6. The traincpg function was used to train the BP neu-
ral networks and the logsig function was used as the transfer function for all of the
BP neural networks. The number of neurons used in the hidden layer of the BP
neural network was altered (ranging from 10 to 600 neurons) in order to improve
performance. A BP neural network with two hidden layers was also tested. The two
layer BP neural network had ten neurons in the first layer and ten neurons in the
second layer. The BP neural network that combined the magnitude and phase data
consisted of a 20-neuron single hidden layer neural network for the magnitude and
20-neuron single hidden layer neural network for the phase with a combined output.
All calculations were performed using Matlab NN Toolbox (Matlab 6, Release 12).
The Hebbian neural network was the first network tested with the raw impedance
magnitude data. This attempt was unsuccessful and the Hebbian neural network
was unable to correctly recognize the signal even at extremely low levels of noise.
By normalizing the data the performance improved slightly, but the Hebbian neural
network was still unable to correctly classify the data (Figure 9.1). The ADALINE
neural network was then tested with raw data and had a recognition error of 93%
for noise levels from 0 to 1. By normalizing the data, the performance of the neural
network was greatly improved with recognition error ranging from 0% to 75%.
The BP neural network with 20 neurons was then tested with the raw magnitude
data. The neural network performed well with recognition errors ranging from 0% to
60% (Figure 9.1). The performance was further improved by normalizing the data
with recognition errors ranging from 0% to 46% (Figure 9.1). The number of neurons
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Figure 9.1: Neural networks with the normalized impedance magni-
tude data. The Hebbian neural network performs poorly.
The ADALINE neural network does a little better. The
backpropagation neural network, however, performs the
best. The data values for the Adaline-Raw, Heb-Raw,
and 2 layer BP network-Raw all overlap at 94% error.
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in the hidden layer was incrementally changed from 10 to 600 (data not shown).
The optimal neural network performance occurred when 20 neurons were used. The
two hidden layer BP neural network was then tested using the raw and normalized
magnitude data. Using the raw data, the recognition error was 93% after training for
all of the noise levels tested. Using the normalized data, performance was significantly
improved and the recognition error ranged from 0 to approximately 50% (Figure 9.1).
The results for the phase data were similar to those collected for the magnitude
data. The Hebbian and the ADALINE neural networks were ineffective. The Heb-
bian had a uniform error of approximately 93%. The ADALINE exhibited similar
results with errors of approximately 93% throughout the entire range of noise levels
(Figure 9.2). This means that the linear training algorithm cannot be effectively used
for the present problem. The BP neural networks performed better than the Hebbian
and ADALINE neural networks with the exception of the two hidden layer BP neural
network, which had a noise level ranging from 82-90% error throughout the entire
noise range (Figure 9.2). The twenty-neuron BP neural network performed well, with
recognition errors ranging from 0 to 58%. The performance of the BP neural network
was not significantly changed by incrementally increasing the number of neurons to
600 (data not shown).
Finally, after evaluating the magnitude and phase separately, the magnitude and
phase data were combined and input into one BP neural network. In order to combine
the magnitude and phase neural networks, the magnitude and phase data were each
trained separately, and the outputs from the two separate networks were combined
before introducing them to the final final output layer with a competitive transfer
function. The code segment used to combine the networks is included below:
P1 = p + randn ( r , s )∗ n o i s e l e v e l ;
A1 = sim ( net , P1 ) ;
P2 = pp + randn ( r , s )∗ n o i s e l e v e l ;
A2 = sim ( net , P2 ) ;
A = (A1.∗A2)/2 ;
AA = compet(A) ;
% Where :
% p = impedance magnitude vec to r
% pp = impedance phase vec to r
% r = 95 ( the s i z e o f the input vec to r )
% s = 16 ( the s i z e o f the output vec to r )
% net = the network t ra ined with magnitude data
% netp = the network t ra ined with phase data
% AA = the f i n a l , combined output
When the magnitude and phase were combined the resultant recognition error
ranged from 0% to 35% (Figure 9.2 labeled as 20neuron mag&phase. This error
range is far superior to that seen with any of the networks trained with magnitude of
phase data alone.
The data from this initial phase of the project clearly indicates the poor per-
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formance of the Hebbian and ADALINE neural networks in the task of correctly
classifying impedance data. The results also illustrate the exemplar performance of
the nonlinear backpropagation neural networks in classifying the impedance spectra.
This has to be expected theoretically since the impedance-pH mapping is a highly
nonlinear process. Based upon these results, backpropagation neural networks were
chosen for further evaluation of the impedance data.
9.2 Part 2: Preprocessing & Parameter Reduction
After deciding upon the use of a backpropagation type neural network as described in
Section 9.1, it was necessary to determine appropriate inputs to the neural network
as well as the number of hidden neurons and layers necessary for the neural network.
In evaluating the different types of neural networks the raw data consisting of 190
impedance phase and magnitude data points were used. As a rule of thumb, ten
sets of data are needed to train each neuron in the network, so to train the network,
in excess of 2000 data sets would be necessary. In order to more efficiently and
effectively train the neural networks, it has been previously established that a set of
20 parameters extracted from the raw impedance data can be used for neural network
development [5]. These parameters are described in Table 9.1.
The twenty parameters described in Table 9.1 were utilized by Borislav Ristic´ [5]
in his custom-made data preprocessing. Additionally, the parameters extracted from
the resistivity dispersion are illustrated in Figure 9.3, those extracted from the reac-
tance curve are illustrated in Figure 9.4, and those extracted from the phase curve
are illustrated in Figure 9.5. The neural network that he utilized was a backpropaga-
tion neural network with twenty inputs (the twenty parameters listed in Table 9.1),
eight hidden neurons, and a single output. The neural network was designed using
NeuralWare Professional Software.
For this work, we wished to further optimize the performance of the neural network
as well as reduce the number of inputs to and connections in the neural network while
maintaining system performance. Neuronal connections were evaluated based on their
weights, and neurons were eliminated when they no longer significantly contributed
to the performance of the network. In order to evaluate the neuronal weights a Hinton
Diagram was utilized (See Figure 9.6).
“The Hinton Diagram is a graphically displayed inter-connection matrix.
All of the processing elements in the network are displayed along the
X-axis as well as the Y-axis. Connections are made assuming that the
outputs of the processing elements are along the X-axis. In this way, all
of the connecting weights for a particular processing element can be seen
by looking at the row of squares to the right of the processing element
displayed on the Y-axis. The input to each weight is the output from the
processing element immediately below along the X-axis.” [49]
The base neural network for evaluation was the neural network designed by
Borislav Ristic´ [5], but trained, using 902 data sets, specifically for this project. From
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Parameter Description
R0 Instantaneous resistance at zero frequency
R∞ Instantaneous resistance at infinite frequency
α Parameter defined in Equation 4.3
τ Model time constant defined in Equation 4.3
REDS Maximum slope for the resistivity dispersion
REDW Width of the dispersion of the resistance
FRECD Central frequency for the resistivity dispersion
PHMAX Minimum impedance phase angle
FPHMAX Frequency of minimum impedance phase angle
PHNSW Width of negative slope of impedance phase angle
PHNS Maximum negative slope of impedance phase angle
PHPS Average positive slope of impedance phase angle
PHSR PHPS/PHNS
IMMAX Minimum of reactance
FIMMAX Frequency of the minimum reactance
IMPS Average positive slope of reactance
IMNS Maximum negative slope of reactance
IMNSW Width of the negative slope of reactance
IMSR IMPS/IMNS
ρ0 R0/R∞
Table 9.1: The 20 impedance parameters extracted from the imped-
ance spectra. R0, R∞, REDS, IMMAX, IMPS, and IMNS
are calculated with impedance values normalized by R∞
[5]
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Figure 9.3: The resistance curve parameters. The parameters illus-
trated are: R0, R∞, REDS, REDW, and FRECD.
this base, two series of neural networks were produced. The first series of neural net-
works was developed by training the base network, then removing all the connections
with a weight of 0.10 or less. After this initial reduction the network was initialized
and retrained. An important note is that the initialization process initializes all of
the weights to random values. This is responsible for slight network variations even
when connections/neurons are not removed. The resultant network was saved and
analyzed before the next parameter reduction took place. For the next reduction and
each subsequent reduction all connections with a network weight of 0.05 or less were
eliminated. The network was then saved and analyzed. The process of saving, analyz-
ing, and reducing the parameters of the network was repeated until two consecutive
networks required no modifications. The connections that were eliminated and the
network revision at which they were eliminated are listed in Table 9.2.
In the second series of neural networks, the base network was initialized and
trained, then starting with the first revision and in all subsequent revisions connec-
tions with a network weight of less than 0.0500 were removed. The network was
then saved, analyzed, and revised until two consecutive network revisions needed no
modifications. The results are listed in Table 9.3.
As mentioned previously, each network revision was analyzed. The analysis con-
sisted of smoothing the estimated and actual pH values using an 11-point smoothing
filter, then calculating the R2 value (correlation coefficient for the estimated vs. ac-
tual pH values), the maximum error (in pH units), the mean error, the RMS error and
the standard deviation of the error for the data collected from six separate ischemic
episodes (928 data sets) were used. The statistical equations used are:
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Figure 9.6: A Hinton diagram. All of the neurons in the network are
listed on the x-axis. The inputs are labeled according to
Table 9.1, the neurons in the hidden layer are labeled
22-28 and the output neuron is labeled 29. The y-axis
lists the neurons in the hidden layer and the output neu-
ron. The boxes graphically represent the weight of the
connection between the corresponding neurons on the x
and y axes.
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Table 9.2: The neural network revisions for series 1. In the first re-
vision, any connection with a weight of less than ±0.1
was removed. In each subsequent revision any connec-
tion with a weight of ±0.05 was removed. In cases where
a value is not listed in the Connections column, the last
listed connection is the connection. The neurons pre-
sented in bold were removed from the network.
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Table 9.3: Series 2 network revisions. Neurons with weights ≥ ±0.05
were removed. If a value is not listed in the Connections
column, refer to the last listed connection. Neurons listed
in bold were removed from the network. Initial weights
in series 1 and 2 differ due to random initialization.
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Correlation Coefficient:
R2 =
n
∑
xy −∑ x ∑ y√
[n
∑
x2 − (∑ x)2][n ∑ y2 − (∑ y)2] (9.1)
Mean Error:
¯ =
∑ |(x− y)|
n
(9.2)
RMS Error:
RMSErr =
√∑
(x− y)2
n
(9.3)
Standard Deviation of the error:
SDErr =
√∑ (− ¯)2
n
(9.4)
In this case, x = estimated pH, y = actual pH, n = samples, and  = error. The
analysis for revisions in which a neuron was eliminated are provided in Table 9.4 and
Table 9.5 as well as the analysis for the terminating revisions. These tables illustrate
that different revisions performed differently for the different cases and some revisions
performed better for different analysis criteria.
In order to determine the network with the best overall performance, an appro-
priate analysis of network performance was necessary. The criteria by which the
networks were judged were the same as those listed in Tables 9.4 and 9.5. Thus, the
network with the highest overall R2 values and the lowest errors would exhibit the
best performance. To achieve an objective evaluation of performance an algorithm
was developed that rated on a scale of 0 to 1 the network performance. In order to
achieve this, a ratio between the best overall performance and the network perfor-
mance for a given characteristic was determined. Thus, the ratio for the best network
performance for each criteria was equal to one, and lesser performance was equal to a
value less than one. Additionally, all of the error performances were averaged before
being averaged with the R2 value so that equal emphasis would be placed on both
R2 values and error characteristics. The algorithm used to determine the optimal
performance is presented in Equation 9.5.
Perform(n) =
R
2
n
R
2
best
+
MaxErrbest
MaxErrn
+
¯best
¯n
+
RMSErrbest
RMSErrn
+
SDErrbest
SDErrn
4
2
(9.5)
In the equation index n refers to the revision number and index best refers to the
optimal performance for the given criteria determined from the total number of revi-
sions. Using this equation, the performance values of the different network revisions,
can easily be compared to each other. A comparison of the different series of networks
and their performance is illustrated in Table 9.6. The difference between the base
neural network and the final revision network is less then 5%, a very small decrease in
performance relative to the 40% decrease in input parameters to the network. Thus,
the reduced input neural networks will be used for clinical data evaluation.
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Exp Stat JJTrain JJRev1 JJRev3 JJRev6 JJRev8 JJRev10 JJRev11 JJRev12 JJRev18 JJRev19 JJRev20 JJRev21 JJRev22
24o4 R2 0.9608 0.9535 0.9553 0.9517 0.9515 0.9657 0.9502 0.9454 0.9556 0.9590 0.9615 0.9701 0.9666
n=70 MaxErr 0.0636 0.1460 0.0864 0.0970 0.1034 0.1311 0.1172 0.1461 0.1188 0.0943 0.1407 0.2142 0.1644
MeanErr 0.0253 0.0393 0.0268 0.0269 0.0336 0.0451 0.0295 0.0373 0.0319 0.0369 0.0387 0.0768 0.0502
RMS Err 0.0311 0.0517 0.0349 0.0333 0.0414 0.0542 0.0380 0.0495 0.0424 0.0437 0.0514 0.0938 0.0649
SDErr 0.0180 0.0336 0.0223 0.0197 0.0242 0.0301 0.0239 0.0324 0.0278 0.0234 0.0339 0.0537 0.0411
25o4 R2 0.9648 0.9746 0.9700 0.9688 0.9689 0.9666 0.9690 0.9717 0.9673 0.9632 0.9686 0.9723 0.9693
n=118 MaxErr 0.1649 0.1669 0.1776 0.1794 0.1750 0.1752 0.1774 0.1691 0.1797 0.1883 0.1778 0.1684 0.1758
MeanErr 0.0947 0.0985 0.1087 0.1091 0.1072 0.1088 0.1064 0.1006 0.1079 0.1134 0.1066 0.1001 0.1054
RMS Err 0.1006 0.1037 0.1133 0.1141 0.1119 0.1138 0.1116 0.1056 0.1135 0.1197 0.1124 0.1060 0.1110
SDErr 0.0342 0.0323 0.0322 0.0333 0.0322 0.0331 0.0335 0.0320 0.0351 0.0382 0.0354 0.0349 0.0349
27o3 R2 0.8442 0.8830 0.8655 0.8732 0.8817 0.8496 0.8691 0.8805 0.8472 0.8359 0.8507 0.8610 0.8495
n=123 MaxErr 0.6614 0.6781 0.6784 0.6778 0.6767 0.6861 0.6685 0.6820 0.6703 0.6838 0.6729 0.6579 0.6748
MeanErr 0.5739 0.5867 0.5976 0.5897 0.5911 0.5990 0.5810 0.5793 0.5837 0.5907 0.5882 0.5786 0.5884
RMS Err 0.5799 0.5941 0.6046 0.5968 0.5974 0.6053 0.5882 0.5871 0.5901 0.5969 0.5950 0.5859 0.5952
SDErr 0.0832 0.0939 0.0915 0.0922 0.0866 0.0873 0.0915 0.0958 0.0870 0.0862 0.0894 0.0920 0.0898
27o4 R2 0.9131 0.8837 0.8955 0.8919 0.8859 0.9071 0.8940 0.8826 0.9112 0.9106 0.9096 0.9005 0.9077
n=308 MaxErr 0.4795 0.5134 0.5109 0.5138 0.5110 0.5189 0.5154 0.5206 0.5238 0.5018 0.5347 0.5673 0.5415
MeanErr 0.3183 0.3390 0.3430 0.3377 0.3407 0.3480 0.3326 0.3300 0.3398 0.3388 0.3445 0.3500 0.3467
RMS Err 0.3411 0.3661 0.3674 0.3636 0.3637 0.3718 0.3594 0.3588 0.3671 0.3615 0.3731 0.3848 0.3759
SDErr 0.1228 0.1384 0.1316 0.1346 0.1271 0.1308 0.1361 0.1409 0.1390 0.1261 0.1432 0.1598 0.1451
28o2 R2 0.5749 0.5862 0.5998 0.6097 0.6228 0.6262 0.6291 0.6556 0.6514 0.6312 0.6205 0.6513 0.6220
n=111 MaxErr 0.2638 0.2311 0.2476 0.2431 0.2402 0.2559 0.2396 0.2364 0.2583 0.2439 0.2662 0.2870 0.2689
MeanErr 0.1598 0.1360 0.1463 0.1467 0.1473 0.1542 0.1470 0.1481 0.1577 0.1484 0.1565 0.1721 0.1586
RMS Err 0.1744 0.1521 0.1615 0.1613 0.1614 0.1682 0.1610 0.1612 0.1708 0.1621 0.1714 0.1861 0.1734
SDErr 0.0698 0.0682 0.0683 0.0670 0.0659 0.0673 0.0654 0.0636 0.0655 0.0653 0.0698 0.0709 0.0700
28o3 R2 0.7447 0.7878 0.7684 0.7798 0.7874 0.7495 0.7839 0.8044 0.7538 0.7598 0.7439 0.7645 0.7406
n=198 MaxErr 0.1456 0.1478 0.1562 0.1531 0.1567 0.1579 0.1570 0.1525 0.1499 0.1490 0.1499 0.1471 0.1516
MeanErr 0.0571 0.0509 0.0551 0.0521 0.0509 0.0577 0.0527 0.0518 0.0566 0.0538 0.0596 0.0602 0.0608
RMS Err 0.0721 0.0647 0.0685 0.0660 0.0650 0.0710 0.0662 0.0644 0.0699 0.0687 0.0719 0.0714 0.0729
SDErr 0.0439 0.0399 0.0406 0.0405 0.0405 0.0413 0.0401 0.0382 0.0410 0.0428 0.0402 0.0385 0.0402
Average R2 0.8337 0.8448 0.8424 0.8458 0.8497 0.8441 0.8492 0.8567 0.8477 0.8433 0.8425 0.8533 0.8426
Max MaxErr 0.6614 0.6781 0.6784 0.6778 0.6767 0.6861 0.6685 0.6820 0.6703 0.6838 0.6729 0.6579 0.6748
Avg. MeanErr 0.2048 0.2084 0.2129 0.2104 0.2118 0.2188 0.2082 0.2078 0.2129 0.2136 0.2157 0.2230 0.2183
Avg. RMS Err 0.2165 0.2221 0.2250 0.2225 0.2235 0.2307 0.2207 0.2211 0.2256 0.2254 0.2292 0.2380 0.2322
Avg. SDErr 0.0620 0.0677 0.0644 0.0646 0.0627 0.0650 0.0651 0.0671 0.0659 0.0637 0.0687 0.0749 0.0702
Table 9.4: Neural network analysis of revisions for series 1. R2, max-
imum error, mean error, RMS error, and the standard
deviation of the error are listed for selected revisions and
each experiment. n is equal to the number of data sets
used. In the experiment titles, the first number is the ex-
periment number, followed by an “o” for occlusion, then
the occlusion number.
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Exp Stat base Rev4 Rev7 Rev8 Rev10 Rev11 Rev19 Rev23 Rev24 Rev32 Rev33
24o4 R2 0.9646 0.9653 0.9527 0.9524 0.9440 0.9377 0.9382 0.9390 0.9283 0.9398 0.9425
n=70 MaxErr 0.0809 0.1156 0.1199 0.1028 0.1262 0.1049 0.1593 0.1088 0.1655 0.1212 0.1374
MeanErr 0.0336 0.0375 0.0465 0.0447 0.0340 0.0306 0.0354 0.0301 0.0373 0.0298 0.0334
RMS Err 0.0394 0.0455 0.0541 0.0514 0.0439 0.0367 0.0519 0.0361 0.0552 0.0370 0.0438
SDErr 0.0205 0.0256 0.0275 0.0254 0.0277 0.0202 0.0379 0.0198 0.0406 0.0218 0.0283
25o4 R2 0.9657 0.9691 0.9722 0.9730 0.9738 0.9723 0.9760 0.9740 0.9747 0.9758 0.9746
n=118 MaxErr 0.1811 0.1792 0.1768 0.1754 0.1776 0.1784 0.1768 0.1805 0.1828 0.1714 0.1711
MeanErr 0.1118 0.1104 0.1067 0.1064 0.1060 0.1056 0.1038 0.1060 0.1055 0.1002 0.0999
RMS Err 0.1169 0.1154 0.1117 0.1112 0.1114 0.1113 0.1100 0.1124 0.1129 0.1059 0.1057
SDErr 0.0340 0.0333 0.0331 0.0323 0.0340 0.0352 0.0362 0.0373 0.0401 0.0343 0.0344
27o3 R2 0.8447 0.8604 0.8755 0.8719 0.8769 0.8832 0.8858 0.8757 0.8906 0.8804 0.8876
n=123 MaxErr 0.6830 0.6768 0.6770 0.6743 0.6846 0.6859 0.6981 0.6910 0.7018 0.6863 0.6804
MeanErr 0.5973 0.5969 0.5868 0.5875 0.5874 0.5868 0.5882 0.5863 0.5891 0.5793 0.5769
RMS Err 0.6032 0.6036 0.5944 0.5951 0.5959 0.5951 0.5979 0.5961 0.5989 0.5891 0.5855
SDErr 0.0838 0.0899 0.0953 0.0949 0.1002 0.0992 0.1072 0.1075 0.1081 0.1068 0.1000
27o4 R2 0.9131 0.9000 0.8860 0.8887 0.8806 0.8688 0.8723 0.8682 0.8673 0.8696 0.8714
n=308 MaxErr 0.5032 0.5095 0.5082 0.5124 0.5182 0.5150 0.5300 0.5189 0.5364 0.5125 0.5183
MeanErr 0.3416 0.3452 0.3361 0.3398 0.3398 0.3392 0.3443 0.3396 0.3487 0.3318 0.3339
RMS Err 0.3634 0.3694 0.3628 0.3665 0.3684 0.3668 0.3766 0.3699 0.3811 0.3631 0.3643
SDErr 0.1241 0.1313 0.1365 0.1372 0.1425 0.1394 0.1526 0.1468 0.1536 0.1473 0.1456
28o2 R2 0.5735 0.5768 0.5968 0.5923 0.6070 0.6196 0.5960 0.6069 0.5891 0.6144 0.6282
n=111 MaxErr 0.2466 0.2415 0.2485 0.2442 0.2446 0.2345 0.2380 0.2340 0.2362 0.2309 0.2249
MeanErr 0.1412 0.1401 0.1494 0.1459 0.1487 0.1467 0.1438 0.1437 0.1449 0.1424 0.1399
RMS Err 0.1576 0.1563 0.1643 0.1611 0.1633 0.1607 0.1591 0.1585 0.1601 0.1570 0.1542
SDErr 0.0701 0.0694 0.0683 0.0683 0.0674 0.0656 0.0681 0.0669 0.0680 0.0661 0.0648
28o3 R2 0.7414 0.7571 0.7799 0.7780 0.7939 0.8163 0.8067 0.8241 0.8200 0.8213 0.8166
n=198 MaxErr 0.1593 0.1584 0.1570 0.1607 0.1551 0.1512 0.1499 0.1501 0.1483 0.1496 0.1510
MeanErr 0.0571 0.0546 0.0543 0.0542 0.0530 0.0478 0.0519 0.0485 0.0486 0.0493 0.0488
RMS Err 0.0715 0.0692 0.0673 0.0676 0.0658 0.0609 0.0642 0.0609 0.0611 0.0615 0.0614
SDErr 0.0430 0.0425 0.0397 0.0403 0.0389 0.0377 0.0378 0.0368 0.0370 0.0367 0.0372
Average R2 0.8338 0.8381 0.8439 0.8427 0.8460 0.8497 0.8458 0.8480 0.8450 0.8502 0.8535
Max MaxErr 0.6830 0.6768 0.6770 0.6743 0.6846 0.6859 0.6981 0.6910 0.7018 0.6863 0.6804
Avg. MeanErr 0.2138 0.2141 0.2133 0.2131 0.2115 0.2095 0.2112 0.2090 0.2123 0.2055 0.2055
Avg. RMS Err 0.2253 0.2266 0.2258 0.2255 0.2248 0.2219 0.2266 0.2223 0.2282 0.2189 0.2191
Avg. SDErr 0.0626 0.0653 0.0667 0.0664 0.0685 0.0662 0.0733 0.0692 0.0746 0.0688 0.0684
Table 9.5: Neural network analysis of revisions for series 2. R2, max-
imum error, mean error, RMS error, and the standard
deviation of the error are listed for selected revisions and
each experiment. n is equal to the number of data sets
used. In the experiment titles, the first number is the ex-
periment number, followed by an “o” for occlusion, then
the occlusion number.
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Set 1 Set 2
Revision Neurons Input Perform Neurons Input Perform
base 29 20 0.9822 29 20 0.9780
1 28 0.9697 0.9839
2 0.9582 0.9772
3 27 0.9699 0.9795
4 0.9688 28 19 0.9754
5 0.9660 0.9796
6 26 19 0.9746 0.9808
7 0.9737 27 0.9772
8 25 18 0.9791 26 18 0.9778
9 0.9684 0.9775
10 24 17 0.9623 25 17 0.9757
11 0.9795 24 0.9842
12 23 16 0.9778 0.9813
13 0.9795 0.9878
14 0.9663 0.9735
15 0.9677 0.9699
16 0.9573 0.9754
17 0.9625 0.9744
18 22 15 0.9714 0.9710
19 20 13 0.9702 23 16 0.9648
20 19 0.9598 0.9711
21 0.9511 0.9709
22 0.9541 0.9719
23 20 14 0.9773
24 19 13 0.9604
25 0.9697
26 0.9714
27 0.9833
28 0.9801
29 0.9690
30 0.9812
31 0.9870
32 0.9840
33 0.9876
% Change 34%↓ 35% ↓ 2.87% ↓ 35%↓ 40% ↓ 0.99% ↑
Table 9.6: Neural network performance values. Neurons represents
the total number of neurons in the network and the
performance value is calculated as illustrated in Equa-
tion 9.5. The last row of the table indicated the percent
change with the ↓ representing a reduction and the ↑ rep-
resenting an increase.In cases where a value is not listed
in the Connections column, the last listed connection is
the connection.
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Stat Raw Filtered
R2 0.7754 0.9223
MaxError 0.3410 0.1498
MeanError 0.0640 0.0497
RMSError 0.0913 0.0633
SDevErr 0.0651 0.0392
Table 9.7: The analysis of results when clinical data was tested using
the neural network from revision 20 series 1.
9.3 Analysis of Clinical Results
After deciding upon the type of neural network to use, and optimizing the neural
network parameters, the final stage of neural network development was to train and
test the network with data collected from clinical trials. In order to do this, the
clinical data was reviewed and the impedance parameters utilized in the final stage
of networks corresponded to the 129 data sets that were determined free from con-
tamination in Chapter 8 and Table 8.1. The 129 data sets were collected from 11
different patients. Ideally a minimal of 190 data points would have been used to train
the neural network, but within the constraints of this project the acquisition of that
volume of data was not possible. The pH values corresponding to the impedance data
were calculated based on the average slope of the pH for the patient from which the
data was taken and the point in time at which the data was collected. After the pH
values corresponding to the impedance parameters was calculated the 129 data sets
were split into a training data set and a testing data set. Two thirds of the data from
each patient was added to the training set for a total of 82 data sets. The remaining
data was added to the testing set for a total of 47 data sets. The 82 data sets in the
training file were then randomized before being used for training the neural networks.
The 47 data sets for testing the neural networks were placed in descending order to
allow for easier post processing of the data.
After selecting the training and testing data sets, the neural network to be trained
had to be selected. The best neural network from each series was selected to be tested
and trained with the clinical impedance data. The network with the fewest number
of input neurons and the highest performance value was considered the best network
for each series. Thus, revision 20 of series 1 was chosen as was revision 33 of series 2.
The results of training and testing revision 20 of series 1 with the clinical data are
illustrated in Table 9.7. The results of the analysis of the raw data, as well as the data
smoothed with an 11 point filter as had been done in prior work are listed. The R2
value of the raw data is 0.775, but is improved to a value of 0.922 with filtering. The
mean error also drops from 0.0640 to 0.0497 with filtering. The actual vs. estimated
pH values are illustrated in Figure 9.7.
The result of training and testing revision 33 of series two with the clinical data
are illustrated in Table 9.8. The results of the analysis of the raw data, as well as the
data smoothed with an 11 point filter as had been done previously are listed. The
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Stat Raw Filtered
R2 0.7470 0.9390
MaxError 0.4627 0.1358
MeanError 0.0632 0.0440
RMSError 0.0972 0.0554
SDevErr 0.0739 0.0338
Table 9.8: The analysis of results when clinical data was tested using
the neural network from revision 33 series 2.
6.7
6.8
6.9
7
7.1
7.2
7.3
7.4
7.5
6.7 6.8 6.9 7 7.1 7.2 7.3 7.4 7.5
Ac
tu
al
 p
H
Estimated pH
Best Fit
Ideal
Figure 9.7: Actual vs. estimated pH for clinical data using the revi-
sion 20 series 1 neural network. The ideal curve (y = x)
and the best fit curve for our data are illustrated in the
figure.
R2 value of the raw data is 0.747, but is improved to a value of 0.939 with filtering.
The mean error also drops from 0.0632 to 0.044. The actual vs. estimated pH values
are illustrated in Figure 9.8. Additionally, an example of the actual pH and the raw
(unsmoothed) estimated pH values vs. time for patient 8 using the revision 20 series
1 neural network is illustrated in Figure 9.9.
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Figure 9.8: Actual vs. estimated pH for clinical data using the revi-
sion 33 series 2 neural network. The ideal curve (y = x)
and the best fit curve for our data are illustrated in the
figure.
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Figure 9.9: Actual vs. estimated pH for patient 8 using the revision
20 series 1 neural network.
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Chapter 10
Discussion
This thesis established important advances on a number of different fronts, from
clinical instrument design improvement to data collection and neural network design.
In this chapter, these and other important contributions will be discussed.
10.1 Clinical Design Improvements
10.1.1 Hardware
The impedance spectrometer and pH meter that were used during this study for
data collection initially were not well suited for the clinical environment. In order to
prepare them for clinical use, a number of system improvements related to the cable
and patient connections were necessary. These problems were solved by creating
a longer cable and labelling the patient leads using paint so the labels would be
unaffected by sterilization.
It was also noted that the constant jostling of the system caused integrated cir-
cuits within the impedance spectrometer to become loose and disconnected. This
problem was solved by reseating the chips and soldering the circuit elements in place.
These problems were observed during instrument preparation and in some of the first
clinical cases (patients 2-4), but the chips were reseated and proper operation ensured
before additional patient data was collected. After these modifications, the system
functioned reliably.
10.1.2 Software
One of the largest design improvements was the addition of the electrosurgical unit
block feature. The electrosurgical unit saturates the voltage we are measuring and
causes irregular recordings for both the impedance measurements as well as the pH
measurements. In order to eliminate the negative effects of the ESU, a software
correction was needed. The software evaluates the incoming data and if the measure-
ments are saturated, it loops back to try again. The modification served its purpose
and eliminated ESU related errors. The modification introduces a timing error into
the data collection that should be evaluated in future work. The ESU saturates the
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electronic components and the pH electrode. Even though the period of ESU use has
been dealt with using the ESU block software modification, further experiments will
be necessary to evaluate the recovery processes of the effected components. Despite
the possible timing and recovery problems, the final version of software utilized was
able to effectively gather both impedance and pH data throughout the procedure. The
data acquired with the final software was all within expected physiological ranges,
but contaminated with varying levels of noise.
10.1.3 Electrodes
The Microelectrode MI-508 electrode had been chosen for use in this study due to
its use in prior research [5, 12]. Unfortunately, there was a high failure rate for these
electrodes, the wiring at the tips seemed to be delicate causing them to become
easily broken when being implanted in the tissue. This problem was lessoned but
not eliminated by modifying the protocol for electrode use to include the use of an
angiocath for probe placement. A sturdier electrode may be desirable for future work.
The ECG electrodes that we were using had only one significant drawback, the
lack of sterility. In order correct for this, the electrodes were placed outside of the
sterile field or, where necessary, inside the field but isolated using steri-drape. For
future research, the availability of sterile or sterilizable electrodes for use with the
impedance spectrometer would be beneficial.
10.1.4 Sterilization
In previous work, ethylene oxide was used to sterilize the pH electrodes [5]. The major
drawback to that method was that the University of Massachusetts Medical Center
(UMMC) only performed the operation twice a week and the procedure takes 12
hours, limiting accessibility to the procedure. For this work, a thorough investigation
indicated that Sterrad sterilization would be preferable. The reasons for this were
twofold. First, Sterrad sterilization is done multiple times daily at UMMC and the
procedure only takes a couple of hours. Thus, it is possible to sterilize the electrodes
quickly and frequently. Additionally, the Sterrad sterilization process takes place at
a lower temperature than the ethylene oxide procedure, and is therefore considered
better for the pH electrodes. This sterilization method proved to be suitable for our
research.
10.2 pH Data
Both laboratory tests and clinical pH measurements were conducted. Laboratory
stability tests were conducted to ensure proper equipment function and use. The
laboratory stability tests performed indicated a drift of 0.00003 pH units per minute
with a standard deviation of 0.0038. The pH data collected in the laboratory showed
that the MI-508 microelectrode provided a stable, reliable measure of a solution’s pH
devoid of electrical interference and motion artifacts. The results in the operating
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room, however, were not stable. The electrosurgical unit interfered with data collec-
tion as did motion artifacts caused by unintentional movement of the probe by the
attending surgeons and nurses.
pH data was collected from a total of sixteen patients. The data from patients
two through seven, however, were heavily contaminated with ESU interference, and
many of the others were contaminated with motion artifacts. In order to select a
contaminant free region of pH data for each patient, the section of data with the
longest continuous decrease in pH was manually selected for further analysis. For our
purposes manual selection of data is scientifically valid because we are not establishing
the fact that there is a decline in pH as a result of ischemia. pH decline during ischemia
has been previously established by a number of sources (See Section 4.6.2). The
final instrument developed will not need to measure pH at all, especially not during
surgeries which present a hostile environment for the pH probe. pH was chosen as a
“golden standard” for this work. Other methods of ischemia monitoring would have
been too invasive, expensive, or would not have permitted continuous monitoring for
the time period required.
Based on the selected points, the average slope of the pH versus time was calcu-
lated for each patient. After eliminating the high and low values, the slopes ranged
from -0.0014 pH/minute to -0.0149 pH/minute with a mean 0f -0.0053 pH/minute.
It is important to note that no studies in human extremity surgery measuring pH
exist, so the rate of change of pH fall was compared to values collected in animal
studies and we found that the values we observed were within the same general range
as those seen in other work (see Section 4.6.2). The average pH slopes reported by
other investigators range from -0.0033 pH/minute to -0.011 pH/minute. Thus, our
average of -0.0053 pH/minute falls in the middle. The variation in pH slope may be
partly due to variations due to tissue/patient differences. It is also similar in magni-
tude to the value reported in rabbit studies using the same instrument by Borislav
Ristic´ of -0.00677pH/minute [5]. Thus, the pH slopes from the selected points can be
considered reasonable.
10.3 Impedance Data
The impedance data for patients 2 through 8 was contaminated by the use of the
electrosurgical unit (ESU). In addition to ESU contamination, much of the data was
contaminated by motion artifacts and noise present at the electrode/patient interface.
The motion artifacts were caused by movement of the patient’s limb, or tugging at the
electrode cable due to its presence in the area in which the surgeons have to function.
As with the pH data, the impedance data was reviewed and the sections of data with
the longest continuous increase in R0 were manually selected and analyzed. R0 was
selected because the behavior of R0 during ischemia had been previously established.
Unlike the pH data, however, the impedance data contaminated with ESU use was
typically devoid of usable data.
Three different impedance parameters were evaluated: R0, IMMAX, and FIM-
MAX. These three parameters were chosen because the behavior of those three pa-
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rameters as a result of ischemia had been previously established [5]. Utilizing data
selected for the longest continuously descending R0 values, the average slope for each
of the three parameters was calculated.
For the selected data, the slope of the R0 data (after dropping the highest and
lowest value) ranged from 0.0531 Ω/minute to 0.3185 Ω/minute with an average slope
of 0.1481 Ω/minute. The R0 value is expected to increase as the tissue becomes more
ischemic due to physiological changes. Thus, our findings are in agreement with the
physiological rationale, and the actual average value that we obtained is on the same
magnitude as the R0 slope recorded from rabbit hind legs during ischemia by Borislav
Ristic´ of 0.1711 Ω/minute [5]. Since the value we recorded is of the same magnitude
as that recorded previously, it can be considered reasonable.
Using the same selected points in time, the slope of the IMMAX (minimum re-
actance) was also evaluated. It has been demonstrated in previous studies that this
value declines as a result of ischemia in skeletal muscle tissue [5]. Our results support
this finding with the slope of IMMAX (after dropping the highest and lowest values)
ranging from -0.0861 to -0.0114 Ω/minute with an average of -0.0545 Ω/minute. The
average decline recorded in previous work was -0.05048. Since the value we recorded
is of the same magnitude as that recorded previously, it can be considered reasonable.
The final parameter evaluated was FIMMAX, the frequency of the minimum re-
actance. As the tissue becomes increasingly ischemic this parameter is also expected
to exhibit a decrease in value [5]. Our results support this finding with the slope of
FIMMAX ranging from -863.02 Hz/minute to -26.49 Hz/minute and an average value
of -354.65 Hz/minute. This result is almost an order of magnitude larger than that
previously recorded by Ristic´ who reported a decline of -88.54 Hz/minute. We could
not tell if this difference was physiological or due to the noisy nature of the signal.
The FIMMAX data we collected exhibited much larger levels of interference than did
the other two parameters evaluated.
At this stage of the research, we cannot give any estimation of the quality of the
remaining 17 impedance parameters. Their variation in ischemia has not yet been
studied and their variations could be the result of physiological properties of the tissue
or may be strictly related to noise in the system.
Despite the selection of identical time points for use in R0, IMMAX, and FIM-
MAX evaluation, large discrepancies in the quality of data exists among the three
parameters. R0 data had the highest quality for the selected time points, and FIM-
MAX exhibited the worst quality. Using the R2 value as an indicator of data quality
and setting an arbitrary threshold of 0.700 as a reasonable quality, only the data
from patients 1, 11, and 14 would be considered to be of reasonable quality for all
three parameters. The large variability in parameter performance is one reason why a
neural network based on the twenty extracted impedance parameters was developed.
Despite the variation in data quality between parameters, the original points selected
for R0 evaluation were used in Section 9.3 of neural network development.
The R0 values used for neural network development were hand-picked. This is
scientifically valid because we are trying to teach an expert system, not evaluate the
performance of the impedance spectrometer. The final instrument will not be used in
the hostile operating room environment, but will be used in a more controlled clinical
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setting.
10.4 Neural Networks
The neural network was developed in three sections: network selection, parameter
reduction, and clinical results analysis. Each of the three sections will be discussed
in detail.
10.4.1 Network Selection
Three different neural network types were evaluated in order to determine the best
neural network for classifying impedance data. The inputs to the network for this trial
were the 95 raw points from either the impedance magnitude spectra or the impedance
phase spectra. The networks were trained and then tested with the same data that
had been input, but with varying levels of noise overlaying the spectra. Based on
the results of those tests, it was determined that the Hebbian and ADALINE neural
networks were ineffective at classifying the impedance spectra even with the lowest
levels of noise, whereas the backpropagation neural network was able to classify data
even under conditions with moderate to heavy noise. Based on the results from this
section, it was determined that a backpropagation neural network would be ideal for
classifying impedance data and the associated pH values.
10.4.2 Parameter Reduction
Based on the results of the network selection phase of the project, it was determined
that the backpropagation neural network is ideal for classifying impedance data. In
that test case, however, all 95 points of the impedance magnitude or phase spectra
were used as inputs to the neural network. For all of the spectral information to be
included in the neural network, that would require 180 inputs to the neural network.
This large number of inputs would require intensive computing to both test and
train the network and could also introduce noise to the network due to irrelevant
or redundant inputs [43]. Due to all of these factors, the decision to use a neural
network with inputs based on parameters extracted from the impedance spectra was
made. After that decision was made, the neural network utilized by Borislav Ristic´
for predicting the pH of ischemic rabbit tissue based on 20 parameters extracted
from the impedance spectra [5] was selected for further study. In order to reduce the
number of data values collected and input to the neural network, as well as to reduce
the number of necessary training data sets, the neural network was optimized based
on network and connection weights. Two series of networks were created, and the
end result for each series was a reduction of the number of neurons in the network by
34% and the number of input neurons by 40%. The change in network performance
based on the reduction of neurons was minimal, there was less than a 5% increase in
the mean error. Based on these results, it was decided that the reduced parameter
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Parameter Series 1 Series 2 Description
R0
√ √
Instantaneous resistance at zero frequency
R∞
√ √
Instantaneous resistance at infinite frequency
α
√ √
Empirical constant between 0 and 1
τ
√ √
Model time constant
REDS
√
– Maximum slope for the resistivity dispersion
FRECD
√
– Central frequency for the resistivity dispersion
PHMAX –
√
Minimum impedance phase angle
FPHMAX
√ √
Frequency of minimum impedance phase angle
PHNS
√ √
Maximum negative slope of impedance phase angle
PHPS
√ √
Average positive slope of impedance phase angle
IMMAX
√ √
Minimum of reactance
FIMMAX
√ √
Frequency of the minimum reactance
IMNS –
√
Maximum negative slope of reactance
IMSR
√ √
IMPS/IMNS
ρ0
√ √
R0/R∞
Table 10.1: The final inputs for the series 1 and series 2 neural net-
works are presented and indicated with a
√
. A brief
description of each input is also presented.
neural networks should be used for analysis of clinical results. Table 10.1 lists the
final inputs for the series 1 and 2 neural networks.
10.4.3 Clinical Results Analysis
The final phase of the neural network analysis was to test it with the data collected
from clinical trials. A total of 129 sets of usable impedance parameters had been
collected from 11 different patients. Unfortunately, the raw pH data corresponding
to these data sets was of poor quality. Assuming that the pH changed linearly with
time, the pH values associated with the 129 data sets were reconstructed based on
the calculated pH slope for the patient associated with the data and the time after
induction of ischemia that the data was collected (See Chapter 7 for details).
The neural networks used clinical data analysis were selected based on the number
of input neurons and the performance values (revision 20 of series one, and revision 33
of series 2). The performance of both of the chosen neural networks were similar and
superior to the performance of the other neural networks. Analysis of the clinical data
showed a correlation coefficient of 0.75 for one and 0.78 for the other. These results
are less than ideal, but are to be expected due the the lack of sufficient numbers of
training data sets. A total of 82 training sets were used when the rule of thumb
indicates that 190 data sets are necessary to properly train the network. When
the estimated pH values are filtered using an eleven point smoothing filter, as was
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done in previous work [5], and also for the evaluation of the parameter reductions,
the correlation coefficients increase to 0.94 and 0.92. These results indicate that the
networks classify impedance data adequately, but that additional research is necessary
to fully establish the relationship between tissue impedance parameters and pH.
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Chapter 11
Conclusion
The long term goal of this research project is to develop a non-invasive instrument for
quantifying human tissue ischemia based on impedance spectroscopic measurements.
Through the course of this thesis, significant advancements towards that goal were
achieved. The main objective of this research was to solve the most important prob-
lems relating to the preparation of the impedance spectrometer for human clinical
applications. In the following evaluation of the initial specific aims and hypothesis,
the accomplishment of that objective will be analyzed.
11.1 Achievement of Aims
In this section, the specific aims as set forth in Chapter 2 will be evaluated. The
manner in which the aims were achieved and the relevant sections in the text will
be explained, or if the aim was not fully achieved, advancements towards the aim
accomplished through this work will be discussed and suggestions for future work will
be set forth.
Prepare Instrument for Clinical Studies
• Identify and perform necessary software/hardware improvements.
Throughout the entire project advances towards this aim were constantly being
made. Important software and hardware improvements were made including
the addition of the ESU block software module and as well as improvements to
the hardware and cable design. These modifications are detailed in Chapter 6
and further explained in Section 10.1. By the end of the project the aim had
been achieved, but through further use of the system in a clinical environment,
additional improvements may be necessary in the dynamic process of perfecting
the instrument for clinical use.
• Determine appropriate electrodes, sterilization and calibration procedures.
This aim was achieved early in the project. The Microelectrode MI-508 pH
electrodes were chosen for pH measurements and the MedicoTest Blue Sensor
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Q-00-A electrodes were chosen for the impedance measurements. The rationale
behind the choice of these electrodes is explained in Section 5.2. After a thor-
ough investigation of sterilization techniques, it was determined that Sterrad
sterilization was ideal for this research (Sections 5.3 and 10.1). Proper cali-
bration protocols for both the impedance spectrometer and the pH meter were
determined (5.4).
• Ensure compatibility with clinical and safety standards.
This aim was achieved prior to operating room activity. In order to ensure
compatibility with clinical safety standards the instrument was inspected by
the Department of Clinical Engineering at UMass Memorial Medical Center
and their recommendations were followed (Chapter 5.1).
Conduct Clinical Studies and Collect Data
• Develop a protocol for data collection
A protocol for data collection was established prior to the first surgical case,
however, through the course of this project additional modifications to the pro-
cedure were made to account for true operating room conditions (Section 5.4.3).
• Record pH and impedance data from 15 bloodless surgeries.
Following the protocol developed in Section 5.4.3, both impedance and pH data
were collected from a total of 16 bloodless extremity surgeries. This achieves
our aim of collecting data from fifteen surgeries. However, due to the poor
quality of much of the data, additional data should be collected for future work.
Analyze the Data
• Develop signal/data preprocessing algorithms as necessary.
A number of steps were taken to preprocess and filter the data, including the
development of the ESU block, the use of previously developed parameter ex-
traction algorithm, and the selection of both pH and impedance points for data
analysis (Sections 6.1, 7.2, 9.2 and Chapter 8). Through the development and
use of the techniques discussed in the sections listed, this aim was achieved.
• Determine the best type of neural network for use classifying impedance data.
Several different types of neural networks were considered (Section 4.7) and
three different neural networks types were tested to evaluate their performance
classifying impedance spectra contaminated with varying levels of noise (Chap-
ter 9.1). The backpropagation neural network exhibited the best performance
and was selected for further use, satisfying this aim.
• Determine the optimal set of impedance inputs for neural network analysis.
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This aim was achieved by evaluating a backpropagation neural network with
twenty extracted parameters as inputs and one hidden layer. Then, based on
network weights, all of the inputs that did not significantly contribute to the
output of the neural network were eliminated (Section 9.2). This resulted in a
40% reduction to the number of necessary inputs to the neural network with
only a 3% decrease in network performance.
• Train and test the neural network with clinical data
The selected backpropagation neural network was trained and then tested with
clinical data (Section 9.3). A clear relationship between parameters of tissue
impedance and pH was not fully achieved. The preliminary results of the data
and neural network analysis suggest that such a relationship does exist, and
through future work can be established.
11.2 Conclusions on Hypotheses
At the beginning of this thesis, four central hypothesis for this research were outlined.
In the following section, each hypothesis will be discussed as well as how our research
supports or refutes each hypothesis.
The first hypothesis was that bloodless extremity surgeries provide a good model
for studying the effects of ischemia on skeletal muscle tissue. This hypothesis was
supported. The bloodless extremity surgeries provide a good model for studying
skeletal muscle ischemia because a tourniquet is used which cuts of blood flow to the
extremity which induces ischemia. The episode is controlled and the patient recovers
fully from the ischemic event. Our results indicate that both the changes in pH and
the impedance changes recorded are consistent with changes due to ischemia. There
are two major drawbacks to the use of bloodless extremity surgeries as a model for
studying ischemia for this work. The first is that the frequent use of the electro-
surgical unit (ESU) during these surgeries, which interferes with the measurements.
With proper system modifications the ESU interference was eliminated. Despite the
success of the ESU blocking system modifications, future work should investigate the
recovery of the system immediately after the use of the ESU. The second drawback is
that it is frequently difficult to achieve proper alignment of electrodes for impedance
monitoring due to space constraints. These drawbacks are minor and can be overcome
through the use of the ESU block software module and through careful placement of
the electrodes.
The second hypothesis was that tissue ischemia can be monitored using non-
invasive impedance measuring techniques. This hypothesis was proven more work
is necessary to improve the quality and accuracy of the technique. The impedance
spectrometer, prior to this research, had only been used to monitor ischemia inva-
sively in an animal model. Through the course of this research it was established
that selected non-invasive ECG electrodes could be used to non-invasively measure
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tissue impedance spectra without introducing significant levels of noise or reducing
the systems bandwidth. The practical use of non-invasive electrodes for use with
impedance spectroscopy was demonstrated in the laboratory, before being used in
clinical trials in order to measure tissue impedance during ischemia. The results
from these measurements indicate that non-invasive impedance measuring techniques
can be successful for monitoring ischemia, however, additional work is necessary to
improve the quality of the measurements.
The third hypothesis was that there is a stable consistent relationship between
pH and parameters of impedance spectra from human skeletal muscle. The work
with neural networks that use impedance parameters as inputs and output pH values
supports this hypothesis. More data is, however, necessary to prove the validity of
the hypothesis.
The fourth hypothesis was that artificial neural networks can be used to generate
algorithms for estimating the pH of tissue based on impedance spectra. This hypoth-
esis is supported by the testing and development of neural network algorithms that,
based on 13 input impedance parameters, estimate the pH of the tissue. Work with
the previously collected data from animal models fully supported the hypothesis. Ad-
ditional work using impedance spectra collected during human clinical studies further
supported the hypothesis. In order to fully prove the hypothesis, however, more data
needs to be collected and tested using the neural networks.
In conclusion, some major hypotheses have been proven and the remaining hy-
potheses were supported by the results of this research, but require additional study
in order to be fully validated. The results of this research support that non-invasive
impedance measurements can be used in a clinical situation to monitor tissue ischemia
and that artificial neural networks can be used to estimate the pH of the tissue based
on a set of impedance parameters extracted from tissue impedance spectra.
11.3 Summary
A number of important steps were made through the course of this work to enable the
realization of a non-invasive ischemia monitor. First, non-invasive electrodes appro-
priate for use in the clinical environment were established (the Blue Sensor Q-00-A).
Then an experimental model, tourniquet surgeries, was established for the evaluation
of the non-invasive ischemia monitor, and both human pH data and impedance spec-
tra were collected in the clinical environment. Evaluation of the pH data established
that the changes in human tissue pH recorded in the clinical environment were con-
sistent with those presented by previous investigators in animal models. Further, the
changes in impedance spectra as a result of ischemia were also consistent with estab-
lished results in an animal model. Thus, both the impedance and pH data collected
during ischemic events in human subjects could be considered valid.
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After establishing the validity of the collected data, appropriate neural networks
were developed in order to establish a relationship between parameters of impedance
spectra and pH. Initial evaluation of different neural networks indicated that a back-
propagation neural network would be appropriate for establishing a relationship be-
tween parameters of impedance spectra and pH. Then, using a previously established
backpropagation neural network, the necessary number of input values to the neural
network were reduced by eliminating unnecessary inputs while maintaining network
performance. Finally, the neural network was trained and tested with impedance
and pH data collected in the clinical environment, and an initial relationship between
parameters of human impedance spectra and pH was established.
It was demonstrated that the ischemia monitor based on impedance spectroscopy
can be successfully used in a clinical environment. Further study will be necessary in
order to develop a concrete relationship between human impedance spectra and pH
as well as provide a stronger establishment of the changes in tissue pH and impedance
as a result of ischemia in tourniquet surgeries.
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Chapter 12
Future Work
Despite the many advancements set forth in this thesis, there are still a number of
issues that need to be solved in order to achieve the long term goal of creating a
fully functional non-invasive/non-contact ischemia measuring device. The impedance
spectrometer needs to undergo more extensive testing in the clinical environment.
The major obstacles to its function in the operating room were overcome throughout
the course of this study, there are, however, a number of obstacles yet to be overcome.
Electrodes
There were a number of difficulties associated with the ECG electrodes used for
impedance monitoring. The ECG electrodes used in this study were adequate, but
sterile ECG electrodes would allow greater flexibility in electrode placement, thus a
number of sterile ECG electrodes for use in impedance monitoring should be evalu-
ated. Additionally, smaller ECG electrodes for use with the impedance spectrometer
would be beneficial. Smaller electrodes would ensure the ability to place all of the
electrodes longitudinally along a single muscle, which would better enable proper
impedance measurements.
The Microelectrode MI-508 electrodes used for pH monitoring in this study also
had shortcomings. The most significant of which was the delicate nature of the
probe head. Six of the pH electrodes were rendered useless because the delicate wires
connected to the tip of the probe broke during the course of surgical implantation or
sterilization. A more rugged pH probe may be desirable for use in further studies,
and therefore an inquiry into available pH probes for surgical use should be made.
Data Collection
This study presented results indicating that non-invasive impedance measurements
can be utilized to estimate tissue pH during ischemia. In order to fully validate these
results, additional data needs to be collected and further statistical analysis will be
necessary.
In addition to collecting a greater quantity of data, the collection of additional
types of data could be potentially useful in further understanding the changes in
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tissue impedance as a function of ischemia. An easy measure of the amount of body
fat surrounding the tissue in question could be valuable in estimating the effect of
subcutaneous fat on the measurements. This measurement could easily be done
using fat calipers to perform a skinfold test on the tricep or thigh depending upon
measurement location [50]. Additionally, calculations could be made to estimate the
body fat using bioimpedance measurements. The body fat calculation is based on
patient height, weight, and the measured impedance at 50kHz. These, and other
methods of estimating the amount of subcutaneous fat should be evaluated as well
as the usefulness of such analysis in this line of research.
The role of the difference between the location of pH probe placement and imped-
ance electrode placement should also be evaluated in order to determine if there is a
time shift in the onset of ischemia between the pH probe and the impedance monitor-
ing electrodes based on the difference in the location of the placements. Compensation
for any affects the difference in placement may cause should be made. The use of
sterile ECG electrodes could limit the effect of placement differences by enabling the
placement of the ECG electrodes within the surgical field.
Neural Networks
In order to fully develop the dat20 and dat33 neural networks presented in this
thesis, additional data should be collected so that each network can be trained with
at least 200 data sets collected during clinical studies. Each network then needs
to be tested with a statistically significant additional number of data sets collected
during clinical studies. Additionally, the backpropagation neural network utilizing
both impedance magnitude and phase data developed using Matlab r© should be
further evaluated as additional data becomes available. This neural network should
be trained with approximately 2000 data sets collected during clinical studies, then
tested with a statistically significant number of data sets collected during clinical
studies. Once adequate quantities of data to test and train the Matlab r© neural
network become available, it may be advantageous to use that neural network because
data preprocessing is not necessary and the accuracy of results may be improved.
pH Monitoring Hardware
The bulky docking station with custom pH interface card should be replaced with a
smaller commercially available PC Card (PCMCIA) technology based pH monitor.
One system that utilizes a PC card for pH monitoring is the SensorLink PCM500
pH for Windows [51]. This and other pH monitoring cards should be evaluated to
determine the product most compatible with our needs. Reducing the bulk of the
system will allow greater mobility within the operating room.
Impedance Spectrometer Hardware
A new impedance spectrometer should be designed which does not have overheating
problems like those experienced in this work and which will improve the impedance
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signal quality. Additionally, redesign of the circuit board should provide greater
system stability.
Finally, a non-contact instrument should be developed in order to overcome the
difficulties associated with numerous wires connecting to the patient and interfering
with the physicians interactions with the patient. A non-contact device based on the
use of eddy currents could also expand the instrument’s applicability so that it could
be used not only for measuring ischemia in skeletal muscle but also buried tissues
such as the heart and brain.
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Appendix A
CD ROM
Due to the large amount of data and software created for this thesis, a CD-ROM has
been included which contains the executable software is124, suepH, all of the Perl
scripts used for data processing and analysis, neural networks developed in Matlab r©,
the Neuralware network revisions that were created, and all of the raw and processed
data. This appendix will explain the use of executables and the type of data found
in the data files.
A.1 is124
is124 is the software that was used in the operating room to collect both impedance
and pH data. It was developed using LabWindows/CVI on a Laptop and executed
using the same laptop. In order to function properly, the docking station with the
custom pH interface card is necessary as is the custom impedance spectrometer. The
executable and associated files are located in the is124 folder on the CD.
A.2 Calibration
All of the calibration files created for the impedance spectrometer are located in a
folder on the CD named calib. Calibration files for two different cables are included.
Also, for each cable, separate files were created for each of the gains (1,3, and 10) and
calibration files for both the saline tank and the 50Ω resistor are included.
A.3 suepH
suepH is the software developed by Susan Shorrock [35] and used for this project to
conduct the two-point pH calibration in the laboratory. The software was developed
in LabWindows/CVI and requires a laptop, docking station, and proprietary pH
interface card. A pH electrode and a reference electrode are also necessary for proper
functioning. The suepH software is located in the suepH folder on the CD.
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A.4 Perl Scripts
A number of different Perl scripts were developed for data analysis purposes. They
are all located in a folder on the CD entitled perl. Each Perl script’s function, in-
puts, and output are described in help files associated with each script. The Perl
scripts were broken into two subfolders based on their function. The first subfolder
is called DataFormat and contains the scripts used to reformat the data: datasort.pl,
stripdata.pl, and imp.pl. The second subfolder is called NeuralNet and contains the
programs used to prepare and analyze the data for use with Neural Networks software:
NNAnalysis.pl, NNRandom.pl, NNTime.pl, mynn.pl and smooth.pl.
datasort.pl
The datasort.pl script is designed to take the *.imp file created by is124 impedance
spectrometer program as its input. It creates an output file named *.txt. The text
in the output file is formatted such that all of the comments are listed first, along
with a number indicating which measurement the comment is associated with. Then,
all of the pH values are listed in order, followed by the impedance magnitude, phase,
error, and parameters. This organization allows for easier interpretation of the data
in spreadsheet programs such as Microsoft Excel.
stripdata.pl
The stripdata.pl script is designed to take the *.txt file output from the datasort.pl
script and reformat it and save it to a new file called *.sht. This function looks for
the comment ’tourniquet up’ and ’tourniquet down’ and saves all of the data that
occurred between the ’tourniquet up’ and tourniquet down’ time in the *.sht file and
disregards the rest of the data. This promotes the easy evaluation of the data during
the ischemic event.
imp.pl
The imp.pl script takes the *.sht file output from stripdata.pl and separates the
different impedance parameters and saves the R0 and the R∞ values into a separate
file. This allows easy evaluation of the R0 and R∞ values in spreadsheet programs.
NNanalysis.pl
The NNanalysis.pl script takes the *.NNR file output from the NeuralWare Neural
Network and analyzes the data and outputs it to the *.dat file. The raw actual and
predicted pH values from the original *.NNR file are evaluated and the slope of the pH
value vs. measurement point is calculated. Then, the actual vs. predicted values are
evaluated and the R2 values, maximum error, mean error, RMS error, and standard
deviation are calculated. After all of these values have been calculated using the raw
data, the raw data is run through an 11 point smoothing filter and all of the values
118
are recalculated. The calculated results for the raw and smoothed data are saved in
*.dat file.
NNrandom.pl
The NNrandom.pl script takes and individual *.txt file and outputs a file called
*.nna. The function takes the impedance parameters and pH values collected during
the animal studies conducted by Borislav Ristic´, randomizes the order (in time) of
the pH values and corresponding impedance parameters, then saves the data in the
format of NeuralWare Neural Networks input files.
NNtime.pl
The NNtime.pl script takes the desired *.txt file as input and outputs a nt*.nna file.
The data input is data collected during animal studies conducted by Borislav Ristic.
The script simply takes the input text file, reformats it to be compatible with the
input files for NeuralWare Neural Networks and saves it to the nt*.nna file. The data
is kept in chronological order.
mynn.pl
The mynn.pl scripts takes the input patient files *.sht and outputs the files *.nna as
well as the file mytrain.nna. The data for this functions is taken from the human
clinical studies. The script first extracts the impedance parameters and associated
pH values. The impedance parameters and associated pH values are then randomized
so that they are no longer presented in chronological order. After randomization, the
data for each patient is saved to the appropriate *.nna file and finally, all of the
patient data is compiled into a single training file and saves as mytrain.nna.
Smooth.pl
The Smooth.pl script takes all of the desired *.txt files as inputs and outputs a file
called trall.nna. The trall.nna file is designed to be the training file for the Neural
Network. Please note that the trall.nna file is created from data collected during
animal studies. It then smoothes the pH data from each subject. After the pH data
has been collected and smoothed for each subject, the pH data from all the subjects
is combined into one array, and randomized. The randomized pH values and their
associated impedance parameters are then formatted to meet the requirements of
NeuralWare Neural Network inputs and are saved as trall.nna to be used training the
neural networks.
A.5 Matlab Neural Networks
The neural networks and the data files associated with them that were developed in
Matlab r© are located in a folder labeled NNThesis. The input files that were used
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for the Matlab neural networks were frequencies.txt, magnitude.txt, phase.txt, and
pH.txt. The .m files with combine in the title were used to compare neural network
outputs. The actual neural network files used for this thesis and presented at the
27th Annual Northeast Bioengineering Conference are located in NNPaper.zip within
the NNThesis folder. The neural network that combined both the magnitude and
phase data, the best of the neural networks evaluated, is called jj20combine.m and
is located in the main NNThesis file along with all of the files required for it to run
successfully.
A.6 NeuralWare Networks
All of the network revisions utilized as well as the data used to train and test the
neural networks are located in a folder labeled NeuralNet.
A.7 Data
The data folder on the CD contains all of the patient data (raw and analyzed).
Within the data folder there is a folder for the data from each patient as well as
folder entitled electrode. The electrode folder chronicles the use, sterilization, and
calibration characteristics for each of the pH electrodes used throughout the course
of this research. The data contained in each patient folder will be described in the
remainder of this section.
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Appendix B
Patient Information
In this Appendix, the patient information and results for the sixteen participants in
the study will be examined. The surgery type, length, and location as well as basic
data quality will be listed.
Patient 1
October 20, 2000
Patient 1 was a 43 year old male undergoing an operation to repair the ulnar
sensory nerve and right ulnar artery on the right arm. The electrodes for impedance
monitoring were placed on the right forearm after the surgical field was established
and isolated with Steri-Drape. The pH electrode (60197) was sutured in place in the
periphery of the wound site. The total tourniquet time was fifty minutes.
Patient 2
November 16, 2000
Patient 2 was a male undergoing an operation on his arm. The ECG electrodes
were placed longitudinally along his forearm. The pH probe (58281) was implanted
in the corner of the surgical site. A kink was noticed at the tip of the pH probe. The
total tourniquet time was 60 minutes.
Patient 3
December 14, 2000
Patient 3 was a male undergoing a flap replantation to the right tibia. The pH
probe (60201) was implanted in the corner of the surgical site. The total tourniquet
time was 120 minutes.
Patient 4
December 15, 2000
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Patient 4 was a 37 year old female undergoing a surgery on her right leg for a
scar revision. The pH probe (60203) was implanted in the tissue using a 12 gauge
angiocath. The total tourniquet time was 60 minutes.
Patient 5
January 9, 2001
Patient 5 was a 45 year old male undergoing a free flap transplant on his left leg.
Electrodes were placed along the right thigh. Due to space constraints, electrode 4
was not placed directly over the same muscle as the other three electrodes. The pH
probe (60197) was implanted in the tissue using the angiocath. The total tourniquet
time was 30 minutes.
Patient 6
January 11, 2001
Patient 6 was an 11 year old male undergoing a nerve transposition and recon-
struction surgery on the right leg. The pH probe (58282) was implanted in the tissue
using the angiocath. A glitch in measurements was also observed when the microscope
was wheeled into the room. The total tourniquet time was 134 minutes.
Patient 7
January 19, 2001
Patient 7 was a 56 year old female smoker undergoing a free flap transplant on
her right leg. Electrodes were placed on the lower thigh. The pH probe (60201)
was implanted in the tissue using the angiocath. The total tourniquet time was 74
minutes.
Patient 8
February 9, 2001
Patient 8 was a 29 year old male undergoing a free flap transplant to the left
leg. The ESU Block was utilized. The pH probe (60197) was implanted using the
angiocath. The total tourniquet time was 85 minutes.
Patient 9
April 10, 2001
Patient 9 was a 38 year old male undergoing an operation on his leg. Electrodes
were placed on the back of the thigh. The pH probe was implanted using an angiocath.
The total tourniquet time was 34 minutes.
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Patient 10
April 10, 2001
Patient 10 was a 32 year old female. Total tourniquet time was 30 minutes.
Patient 11
April 26, 2001
Patient 11 was a 53 year old male undergoing a surgery to repair a right ankle
wound. The electrodes for impedance monitoring were placed on his inner thigh. The
pH probe (57168) was implanted using an angiocath. The total tourniquet time was
28 minutes.
Patient 12
April 26, 2001
Patient 12 was a 21 year old female undergoing a surgery to repair her right flexor
tendon. The electrodes for impedance monitoring were placed on her upper arm. The
pH probe (58283) was implanted using an angiocath. The total tourniquet time was
50 minutes.
Patient 13
May 8, 2001
Patient 13 was a 43 year old male undergoing a surgery for free flap transplantation
to the right leg. The electrodes for impedance monitoring were placed on the right
lateral thigh. The pH probe (57168) was implanted using an angiocath. The total
tourniquet time was 47 minutes.
Patient 14
May 8, 2001
Patient 14 was a 13 year old male undergoing a nerve release surgery on his left
fingers. The impedance monitoring electrodes were placed on the upper arm. The
pH probe (58283) was implanted using an angiocath. The total tourniquet time was
80 minutes.
Patient 15
May 17, 2001
Patient 15 was a 44 year old female undergoing the amputation of all ten toes.
Electrodes were set up on the right calf. The total tourniquet time was 70 minutes.
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Patient 16
June 7, 2001
Patient 16 was a 21 year old male undergoing a tendon graft to the left leg.
The impedance monitoring electrodes were placed on the thigh. The tourniquet was
inflated/deflated twice. The first time, the tourniquet was up for 32 minutes. The
second period of tourniquet inflation is what was used in this study and had a duration
of 42 minutes.
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Appendix C
Patient Consent Form
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Appendix E
Photo Gallery
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Figure E.1: Prior to surgery and electrode application the surgical
site is prepared.
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Figure E.2: Electrode placement within the surgical field.
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Figure E.3: Prof. Steve Kun and Jocelyn Songer ready to get to
work.
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Figure E.4: Placement of electrodes outside of the sterile field.
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Figure E.5: Placement of pH probe in surgical site. The pH probe
is what appears as a white wire in the photograph and
the tip of the probe is embedded in the muscle.
139
Figure E.6: Jocelyn Songer with the ischemia monitor in the OR.
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Figure E.7: Placement of the pH probe directly in the tissue. Note
the pH probe appears as a white wire in the photograph
and the tip of the probe is implanted through the skin
and into the muscle below.
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Figure E.8: The instrument in the OR.
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Figure E.9: The flurry of activity around the surgical site.
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Figure E.10: The pH probe implanted using a 12 gauge angiocath
in the gastrocnemius. Dr. Dunn is operating on the
patient’s foot.
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Figure E.11: The pH probe implanted using a 12 gauge angiocath
in the gastrocnemius. Dr. Dunn is operating on the
patient’s foot.
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